Unnamed: 0
stringlengths 3
9
| Date
stringlengths 23
23
| Article_title
stringlengths 12
250
| Stock_symbol
stringlengths 1
5
| Url
stringlengths 35
135
| Publisher
stringclasses 80
values | Author
stringclasses 1
value | Article
stringlengths 1
343k
| Lsa_summary
stringlengths 3
14.4k
| Luhn_summary
stringlengths 1
14.7k
| Textrank_summary
stringlengths 1
14.6k
| Lexrank_summary
stringlengths 1
14.3k
| uuid
stringlengths 36
36
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
6.0
|
2023-11-24 00:00:00 UTC
|
The Zacks Analyst Blog Highlights Visa, Marriott International, Parker-Hannifin, FedEx and Agilent Technologies
|
A
|
https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights-visa-marriott-international-parker-hannifin-fedex-and
|
nan
|
nan
|
For Immediate Release
Chicago, IL – November 24, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Visa Inc. V, Marriott International, Inc. MAR, Parker-Hannifin Corp. PH, FedEx Corp. FDX and Agilent Technologies, Inc. A.
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Visa, Marriott International and Parker-Hannifin
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc., Marriott International, Inc. and Parker-Hannifin Corp. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Visa's shares have outperformed the Zacks Financial Transaction Services industry over the past year (+20.9% vs. +15.7%). The company's stock prices has consistently outperformed the industry, driven by strategic acquisitions and alliances fostering long-term growth.
The fourth quarter fiscal 2023 earnings beat estimates, fueled by increased payments and sustained investments in technology. The ongoing shift to digital payments is advantageous for Visa, with strong domestic volumes supporting overall performance. A robust cash position enables the company to enhance shareholder value.
However, elevated operating expenses pose margin challenges. Increased client incentives may impact the top line. Additionally, it is witnessing a declining cash volume from the Asia Pacific and CEMEA regions. As such the stock warrants a cautious stance.
(You can read the full research report on Visa here >>>)
Shares of Marriott International have outperformed the Zacks Hotels and Motels industry over the year-to-date period (+40.6% vs. +22.9%). The company's upside was backed by robust leisure demand and solid global booking trends.
Also, substantial RevPAR growth in international markets added to the upside. In the quarter, RevPAR for worldwide comparable system-wide properties increased 8.8% year over year. Also, the emphasis on expansion initiatives, digital innovation and the loyalty program bode well.
During the quarter, the company added 97 properties to its worldwide lodging portfolio. However, challenging macroeconomic conditions and high debt remain a concern. Earnings estimates for 2023 have declined in the past 30 days.
(You can read the full research report on Marriott International here >>>)
Shares ofParker-Hannifin have outperformed the Zacks Manufacturing - General Industrial industry over the year-to-date period (+51.1% vs. +12.0%). The company is benefiting from higher demand from distributors and end users across the oil and gas, material handling, cars and light trucks, and farm and agriculture markets in the North American region within the Diversified Industrial segment.
Higher volume across all businesses, especially the commercial and military aftermarket businesses bolstered the company's Aerospace Systems unit. Synergies from the Meggitt buyout (September 2022) are also aiding the company. Benefits from the Win strategy are driving Parker-Hannifin's margins. The company's measures to add shareholder value hold promise.
However, the escalating cost of sales and rising selling, general and administrative expenses pose a threat to its bottom line. Foreign currency headwinds may dent PH's top line. A weak liquidity position is also worrisome.
(You can read the full research report on Parker-Hannifin here >>>)
Other noteworthy reports we are featuring today include FedEx Corp. and Agilent Technologies, Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Visa Inc. (V) : Free Stock Analysis Report
Marriott International, Inc. (MAR) : Free Stock Analysis Report
Parker-Hannifin Corporation (PH) : Free Stock Analysis Report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
FedEx Corporation (FDX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Stocks recently featured in the blog include: Visa Inc. V, Marriott International, Inc. MAR, Parker-Hannifin Corp. PH, FedEx Corp. FDX and Agilent Technologies, Inc. A. The company is benefiting from higher demand from distributors and end users across the oil and gas, material handling, cars and light trucks, and farm and agriculture markets in the North American region within the Diversified Industrial segment. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security.
|
Stocks recently featured in the blog include: Visa Inc. V, Marriott International, Inc. MAR, Parker-Hannifin Corp. PH, FedEx Corp. FDX and Agilent Technologies, Inc. A. Here are highlights from Wednesday’s Analyst Blog: Top Research Reports for Visa, Marriott International and Parker-Hannifin The Zacks Research Daily presents the best research output of our analyst team. Click to get this free report Visa Inc. (V) : Free Stock Analysis Report Marriott International, Inc. (MAR) : Free Stock Analysis Report Parker-Hannifin Corporation (PH) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report FedEx Corporation (FDX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Here are highlights from Wednesday’s Analyst Blog: Top Research Reports for Visa, Marriott International and Parker-Hannifin The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc., Marriott International, Inc. and Parker-Hannifin Corp. Click to get this free report Visa Inc. (V) : Free Stock Analysis Report Marriott International, Inc. (MAR) : Free Stock Analysis Report Parker-Hannifin Corporation (PH) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report FedEx Corporation (FDX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Here are highlights from Wednesday’s Analyst Blog: Top Research Reports for Visa, Marriott International and Parker-Hannifin The Zacks Research Daily presents the best research output of our analyst team. A robust cash position enables the company to enhance shareholder value. In the quarter, RevPAR for worldwide comparable system-wide properties increased 8.8% year over year.
|
edc7a891-10e9-4710-941b-77d92f360017
|
18.0
|
2023-11-16 00:00:00 UTC
|
Daily Dividend Report: CSCO,CB,EXR,NOC,A,PHM
|
A
|
https://www.nasdaq.com/articles/daily-dividend-report%3A-cscocbexrnocaphm
|
nan
|
nan
|
Cisco has declared a quarterly dividend of $0.39 per common share to be paid on January 24, 2024, to all stockholders of record as of the close of business on January 4, 2024.
The Board of Directors of Chubb today declared a quarterly dividend equal to $0.86 per share, payable on January 5, 2024 to shareholders of record at the close of business on December 15, 2023. The dividend will be payable out of legal reserves and will be made in United States dollars by the company's transfer agent, as described in the Chubb Limited 2023 proxy statement. This will be the third installment as approved by the company's shareholders on May 17, 2023.
Extra Space Storage announced today that the Company's board of directors has declared a fourth quarter 2023 dividend of $1.62 per share on the common stock of the Company. The dividend is payable on December 29, 2023 to stockholders of record at the close of business on December 15, 2023.
The board of directors of Northrop Grumman declared a quarterly dividend of $1.87 per share on Northrop Grumman common stock, payable Dec. 13, 2023, to shareholders of record as of the close of business Nov. 27, 2023.
Agilent Technologies today announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend. The quarterly dividend will be paid on Jan. 24, 2024, to all shareholders of record as of the close of business on Jan. 2, 2024.
PulteGroup announced today that its Board of Directors has voted to increase the Company's quarterly dividend by 25% to $0.20 per common share. The increase will be effective with the Company's next scheduled dividend, which is payable January 3, 2024, to shareholders of record at the close of business on December 19, 2023.
VIDEO: Daily Dividend Report: CSCO,CB,EXR,NOC,A,PHM
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The Board of Directors of Chubb today declared a quarterly dividend equal to $0.86 per share, payable on January 5, 2024 to shareholders of record at the close of business on December 15, 2023. The dividend will be payable out of legal reserves and will be made in United States dollars by the company's transfer agent, as described in the Chubb Limited 2023 proxy statement. The increase will be effective with the Company's next scheduled dividend, which is payable January 3, 2024, to shareholders of record at the close of business on December 19, 2023.
|
The Board of Directors of Chubb today declared a quarterly dividend equal to $0.86 per share, payable on January 5, 2024 to shareholders of record at the close of business on December 15, 2023. Extra Space Storage announced today that the Company's board of directors has declared a fourth quarter 2023 dividend of $1.62 per share on the common stock of the Company. The board of directors of Northrop Grumman declared a quarterly dividend of $1.87 per share on Northrop Grumman common stock, payable Dec. 13, 2023, to shareholders of record as of the close of business Nov. 27, 2023.
|
The Board of Directors of Chubb today declared a quarterly dividend equal to $0.86 per share, payable on January 5, 2024 to shareholders of record at the close of business on December 15, 2023. The board of directors of Northrop Grumman declared a quarterly dividend of $1.87 per share on Northrop Grumman common stock, payable Dec. 13, 2023, to shareholders of record as of the close of business Nov. 27, 2023. Agilent Technologies today announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend.
|
The Board of Directors of Chubb today declared a quarterly dividend equal to $0.86 per share, payable on January 5, 2024 to shareholders of record at the close of business on December 15, 2023. PulteGroup announced today that its Board of Directors has voted to increase the Company's quarterly dividend by 25% to $0.20 per common share. The increase will be effective with the Company's next scheduled dividend, which is payable January 3, 2024, to shareholders of record at the close of business on December 19, 2023.
|
b2ecb549-7fb5-4167-8a31-056210238b21
|
31.0
|
2023-10-17 00:00:00 UTC
|
Carl Icahn sues Illumina board for violating 'fiduciary duties'
|
A
|
https://www.nasdaq.com/articles/carl-icahn-sues-illumina-board-for-violating-fiduciary-duties
|
nan
|
nan
|
Changes source in headline, recasts paragraph 1, adds background in paragraphs 4-6
Oct 17 (Reuters) - Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina ILMN.O and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday.
The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail.
Illumina said it is reviewing the complaint, while Icahn and Grail did not immediately respond to Reuters requests for a comment.
The gene-sequencing machine maker had repurchased Grail in 2021 despite opposition from U.S. and European antitrust regulators - a decision that prompted Icahn to pursue a proxy fight at Illumina, arguing Grail should be divested as it had cost investors billions of dollars.
Last week, Illumina said it would divest cancer test maker Grail in 12 months according to the terms of the European Commission's order, if the life sciences company does not win its challenge in court.
(Reporting by Mrinmay Dey and Shivani Tanna in Bengaluru; Editing by Sherry Jacob-Phillips)
((Mrinmay.Dey@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Changes source in headline, recasts paragraph 1, adds background in paragraphs 4-6 Oct 17 (Reuters) - Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina ILMN.O and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday. The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail. Last week, Illumina said it would divest cancer test maker Grail in 12 months according to the terms of the European Commission's order, if the life sciences company does not win its challenge in court.
|
Changes source in headline, recasts paragraph 1, adds background in paragraphs 4-6 Oct 17 (Reuters) - Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina ILMN.O and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday. The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail. Last week, Illumina said it would divest cancer test maker Grail in 12 months according to the terms of the European Commission's order, if the life sciences company does not win its challenge in court.
|
Changes source in headline, recasts paragraph 1, adds background in paragraphs 4-6 Oct 17 (Reuters) - Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina ILMN.O and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday. The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail. The gene-sequencing machine maker had repurchased Grail in 2021 despite opposition from U.S. and European antitrust regulators - a decision that prompted Icahn to pursue a proxy fight at Illumina, arguing Grail should be divested as it had cost investors billions of dollars.
|
Changes source in headline, recasts paragraph 1, adds background in paragraphs 4-6 Oct 17 (Reuters) - Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina ILMN.O and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday. The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail. Illumina said it is reviewing the complaint, while Icahn and Grail did not immediately respond to Reuters requests for a comment.
|
6f350503-0ec3-407c-9fad-f6c2c26867ad
|
32.0
|
2023-10-10 00:00:00 UTC
|
Agilent (A) Bolsters NTD Research With SIDC Partnership
|
A
|
https://www.nasdaq.com/articles/agilent-a-bolsters-ntd-research-with-sidc-partnership
|
nan
|
nan
|
Agilent Technologies A signed a Memorandum of Understanding with the Sarawak Infectious Disease Centre (SIDC) to provide its 6475 triple quadrupole LC/MS system for neglected tropical diseases (NTD) research.
Notably, Agilent's 6475 LC/MS, which utilizes iFunnel technologies, will aid SIDC's research on tropical medicines and infectious diseases, enabling rapid outbreak response through extensive research and diagnostic capabilities.
Further, the 6475 LC/MS system enhances signal response and optimizes research outcomes through technology and knowledge transfer, capacity building, research programs and human capital development.
SIDC plans to use Agilent's capabilities as it prepares for facility completion by December 2025.
We note that the latest move has expanded the customer base of Agilent’s liquid chromatography mass spectrometry (LC/MS) systems. This, in turn, will strengthen Agilent’s Life Sciences & Applied Markets Group (LSAG) segment.
Moreover, the deal will also strengthen Agilent’s footprint in Asian markets.
Agilent Technologies, Inc. Price and Consensus
Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote
Growth Prospects
We believe that the latest move will strengthen the company’s footing in the global neglected tropical diseases diagnosis market.
Per an MMR research report, the global NTD diagnosis market size is expected to reach $8.97 billion by 2029, exhibiting a CAGR of 4.5% between 2022 and 2029.
A Grand View Research report predicts the global NTD diagnosis market size to witness a CAGR of 4.5% during the forecast period of 2023-2030.
We believe the company’s solid prospects in the promising NTD diagnosis market are expected to instill investor optimism in the stock.
However, it has been suffering from macroeconomic uncertainties, weak momentum in China, rising inflationary pressure and geo-political tensions.
Agilent has lost 25.6% in the year-to-date period, underperforming the industry’s growth of 0.8%.
LSAG Segment in Focus
The latest move is in sync with the company’s growing efforts toward bolstering its LSAG segment.
Apart from the latest move, Agilent Technologies showcased its expanded InfinityLab GPC/SEC Solution at the HPLC Conference 2023 in Düsseldorf. The solution includes a dedicated column thermostat, multi-angle light scattering detector, GPC/SEC-Ready Kit, and WinGPC Software for advanced material characterization.
Additionally, Agilent's 1260 Infinity II Hybrid Multisampler, 1290 Infinity II Bio Online Sample Manager and Revident Quadrupole Time-of-Flight LC/MS System were also displayed at the HPLC 2023 conference.
Further, Agilent Technologies introduced new liquid chromatography mass spectrometry systems, Agilent 6495D LC/TQ and Revident LC/Q-TOF, along with new software for profiling and library management, ensuring high analytical sensitivity and efficiency for fast, high-quality data and early maintenance feedback for optimal performance.
Also, Agilent launched the Agilent 8697 Headspace Sampler -XL Tray, offering 120 vial capacity and enhanced instrument intelligence features for increased uptime and operator ease of use compared to its predecessor.
All these endeavors are likely to aid the performance of the LSAG segment in the days ahead.
However, the sluggish pharma market continues to remain a concern.
Our model estimate for LSAG revenues for fiscal 2023 is pegged at $3.85 billion, indicating a decline of 3.9% from the fiscal 2022 level.
Zacks Rank & Stocks to Consider
Currently, Agilent carries a Zacks Rank #5 (Strong Sell).
Some better-ranked stocks in the broader technology sector are Asure Software ASUR, Applied Materials AMAT and Arista Networks ANET. While Asure Software and Applied Materials sport a Zacks Rank #1 (Strong Buy) each, Arista Networks carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Asure Software shares have lost 2% in the year-to-date period. ASUR’s long-term earnings growth rate is currently projected at 27%.
Applied Materials shares have gained 43.9% in the year-to-date period. AMAT’s long-term earnings growth rate is currently projected at 6.10%.
Arista Networks shares have gained 61.8% in the year-to-date period. The long-term earnings growth rate for ANET is currently projected at 18.75%
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Applied Materials, Inc. (AMAT) : Free Stock Analysis Report
Asure Software Inc (ASUR) : Free Stock Analysis Report
Arista Networks, Inc. (ANET) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Per an MMR research report, the global NTD diagnosis market size is expected to reach $8.97 billion by 2029, exhibiting a CAGR of 4.5% between 2022 and 2029. A Grand View Research report predicts the global NTD diagnosis market size to witness a CAGR of 4.5% during the forecast period of 2023-2030. The solution includes a dedicated column thermostat, multi-angle light scattering detector, GPC/SEC-Ready Kit, and WinGPC Software for advanced material characterization.
|
Some better-ranked stocks in the broader technology sector are Asure Software ASUR, Applied Materials AMAT and Arista Networks ANET. While Asure Software and Applied Materials sport a Zacks Rank #1 (Strong Buy) each, Arista Networks carries a Zacks Rank #2 (Buy). Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Applied Materials, Inc. (AMAT) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Agilent Technologies, Inc. Price and Consensus Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote Growth Prospects We believe that the latest move will strengthen the company’s footing in the global neglected tropical diseases diagnosis market. Further, Agilent Technologies introduced new liquid chromatography mass spectrometry systems, Agilent 6495D LC/TQ and Revident LC/Q-TOF, along with new software for profiling and library management, ensuring high analytical sensitivity and efficiency for fast, high-quality data and early maintenance feedback for optimal performance. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Applied Materials, Inc. (AMAT) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Notably, Agilent's 6475 LC/MS, which utilizes iFunnel technologies, will aid SIDC's research on tropical medicines and infectious diseases, enabling rapid outbreak response through extensive research and diagnostic capabilities. Agilent Technologies, Inc. Price and Consensus Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote Growth Prospects We believe that the latest move will strengthen the company’s footing in the global neglected tropical diseases diagnosis market. Some better-ranked stocks in the broader technology sector are Asure Software ASUR, Applied Materials AMAT and Arista Networks ANET.
|
a725bd50-85f0-4087-bf60-9b5fb28f40ae
|
33.0
|
2023-10-05 00:00:00 UTC
|
Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar
|
A
|
https://www.nasdaq.com/articles/q4-stock-predictions%3A-3-sp-500-stocks-ready-to-soar
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Stocks ended the third quarter on a sour note. The Federal Reserve’s aggressive posture against inflation combined with soaring interest rates have investors taking defensive measures.
But it’s not time to give up on the stock market. In fact, thanks to the recent selling, bargains are springing up across many S&P 500 stocks.
Let’s examine three that will benefit from current market conditions and rally heading into 2024.
Wells Fargo (WFC)
Source: Ken Wolter / Shutterstock.com
Wells Fargo (NYSE:WFC) is one of the big banks that is thriving amid the industry’s correction. That’s because Wells Fargo did not aggressively expand its balance sheet or buy overvalued securities over the past few years.
True, investors have shunned nearly all financials stocks this year amid unprecedented volatility in the interest rate markets. Banks that were positioned poorly, like First Republic and Silicon Valley, ended up going bust. And others are suffering from falling profitability and strained balance sheets at the present time.
Meanwhile, Wells Fargo has positioned its balance sheet to earn far more profits as interest rates rise. And those rates are normally beneficial to the banking sector as a whole. For firms like Wells Fargo that managed their risks and exposures properly, that remains true in 2023.
Specifically, Wells Fargo’s net interest margin (NIM), the spread between its loan interest and deposit payments, has soared from 2.2% in Q2 of last year to 3.1% today. With a near 50% jump in core profitability on its loan book, it’s no wonder that Wells Fargo is reporting rising earnings. WFC stock hasn’t yet snapped out of the industrywide doldrums. As a result, shares go for just eight times forward earnings today.
Charles River Laboratories (CRL)
Source: IgorGolovniov / Shutterstock.com
Charles River Laboratories (NYSE:CRL) is a leading healthcare company focused on providing lab tools and services related to pharmaceutical drug development.
Historically, it’s been the dominant player in animal models. Specifically, Charles River procures, breeds, and distributes lab rats, mice, rabbits, and non-human primates. The last one got Charles River in trouble, as the company was implicated in an investigation into alleged macaque smuggling in Cambodia. However, as of last quarter, Charles River has been able to resolve its sourcing issues around non-human primates.
More broadly, CRL stock has slumped amid the slowdown in the biotech industry. With smaller biotech companies struggling to obtain funding, Charles River is experiencing less trials and revenue-generating business. Yet, it’s only a matter of time until biotech funding rises again, given the priority to find cures for rare diseases.
CRL will inevitably be part of those future cures. In fact, the company was involved in developing more than 80% of all drugs that received FDA approval since 2020. In effect, Charles River is a tax on the entire biotech industry, with their consistent postings of compounded earnings per share growth rate in the teens since the turn of the century.
Thanks to the recent scandal and biotech industry’s slump, CRL shares are now on sale at an unusually low 18 times forward earnings.
Keysight Technologies (KEYS)
Source: Funtap / Shutterstock.com
Keysight Technologies (NYSE:KEYS) is a company that provides testing, product quality, and design solutions to technology companies. The firm has an interesting history.
Keysight sprung up originally as Hewlett-Packard‘s Test & Measurement division more than half a century ago, and was ultimately spun off from Agilent (NYSE:A) into its own publicly-traded entity in 2014.
KEYS stock has been incredibly successful over the past decade. Since 2014, shares jumped from $30 to a peak of more than $200. However, Keysight has fallen amid a slowdown in telecom and information technology spending over the past year. That has led KEYS stock to slide back to around $130 today.
The weakness makes sense, as Keysight is heavily involved in quality control and testing for telecom companies. With 5G rollouts seeing an underwhelming debut as compared to expectations, that has cast a shadow on industry vendors. Other Keysight segments such as services for edge computing and RFID functions have slipped as demand levels off following an unusually robust 2021 and 2022.
Indeed, the market is blowing the situation way out of proportion. KEYS stock is down to 16 times forward earnings, which is quite the discount for a tech company that has reliably posted double-digit earnings growth. It’s only a matter of time until telecom spending picks back up given the ever-growing demand for mobile data.
Also, Keysight is active in emerging growth fields such as AI and next-generation semiconductors. Investors should take advantage of the current dip in KEYS stock.
On the date of publication, Ian Bezek held a long position in KEYS, CRL, and WFC stock. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Ian Bezek has written more than 1,000 articles for InvestorPlace.com and Seeking Alpha. He also worked as a Junior Analyst for Kerrisdale Capital, a $300 million New York City-based hedge fund. You can reach him on Twitter at @irbezek.
More From InvestorPlace
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The Federal Reserve’s aggressive posture against inflation combined with soaring interest rates have investors taking defensive measures. In effect, Charles River is a tax on the entire biotech industry, with their consistent postings of compounded earnings per share growth rate in the teens since the turn of the century. Keysight sprung up originally as Hewlett-Packard‘s Test & Measurement division more than half a century ago, and was ultimately spun off from Agilent (NYSE:A) into its own publicly-traded entity in 2014.
|
Wells Fargo (WFC) Source: Ken Wolter / Shutterstock.com Wells Fargo (NYSE:WFC) is one of the big banks that is thriving amid the industry’s correction. Charles River Laboratories (CRL) Source: IgorGolovniov / Shutterstock.com Charles River Laboratories (NYSE:CRL) is a leading healthcare company focused on providing lab tools and services related to pharmaceutical drug development. Keysight Technologies (KEYS) Source: Funtap / Shutterstock.com Keysight Technologies (NYSE:KEYS) is a company that provides testing, product quality, and design solutions to technology companies.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Stocks ended the third quarter on a sour note. Charles River Laboratories (CRL) Source: IgorGolovniov / Shutterstock.com Charles River Laboratories (NYSE:CRL) is a leading healthcare company focused on providing lab tools and services related to pharmaceutical drug development. Keysight Technologies (KEYS) Source: Funtap / Shutterstock.com Keysight Technologies (NYSE:KEYS) is a company that provides testing, product quality, and design solutions to technology companies.
|
But it’s not time to give up on the stock market. True, investors have shunned nearly all financials stocks this year amid unprecedented volatility in the interest rate markets. Meanwhile, Wells Fargo has positioned its balance sheet to earn far more profits as interest rates rise.
|
c2253c1e-3bc8-4a96-ab87-7f4fbde201c7
|
34.0
|
2023-09-29 00:00:00 UTC
|
Barclays Maintains Agilent Technologies (A) Underweight Recommendation
|
A
|
https://www.nasdaq.com/articles/barclays-maintains-agilent-technologies-a-underweight-recommendation-0
|
nan
|
nan
|
Fintel reports that on September 29, 2023, Barclays maintained coverage of Agilent Technologies (NYSE:A) with a Underweight recommendation.
Analyst Price Forecast Suggests 26.87% Upside
As of August 31, 2023, the average one-year price target for Agilent Technologies is 142.10. The forecasts range from a low of 111.10 to a high of $171.15. The average price target represents an increase of 26.87% from its latest reported closing price of 112.00.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Agilent Technologies is 7,130MM, an increase of 1.94%. The projected annual non-GAAP EPS is 5.77.
What is the Fund Sentiment?
There are 1926 funds or institutions reporting positions in Agilent Technologies. This is a decrease of 104 owner(s) or 5.12% in the last quarter. Average portfolio weight of all funds dedicated to A is 0.31%, a decrease of 19.13%. Total shares owned by institutions decreased in the last three months by 1.89% to 296,536K shares.
The put/call ratio of A is 0.70, indicating a bullish outlook.
What are Other Shareholders Doing?
Massachusetts Financial Services holds 11,037K shares representing 3.77% ownership of the company. In it's prior filing, the firm reported owning 8,907K shares, representing an increase of 19.30%. The firm increased its portfolio allocation in A by 3.73% over the last quarter.
T. Rowe Price Investment Management holds 9,968K shares representing 3.41% ownership of the company. In it's prior filing, the firm reported owning 9,277K shares, representing an increase of 6.93%. The firm decreased its portfolio allocation in A by 11.26% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,177K shares representing 3.14% ownership of the company. In it's prior filing, the firm reported owning 9,160K shares, representing an increase of 0.18%. The firm decreased its portfolio allocation in A by 19.66% over the last quarter.
Wellington Management Group Llp holds 8,736K shares representing 2.99% ownership of the company. In it's prior filing, the firm reported owning 12,057K shares, representing a decrease of 38.01%. The firm decreased its portfolio allocation in A by 39.89% over the last quarter.
Price T Rowe Associates holds 8,054K shares representing 2.75% ownership of the company. In it's prior filing, the firm reported owning 8,219K shares, representing a decrease of 2.05%. The firm increased its portfolio allocation in A by 78.88% over the last quarter.
Agilent Technologies Background Information
(This description is provided by the company.)
Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward improving the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
Click to Learn More
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Fintel reports that on September 29, 2023, Barclays maintained coverage of Agilent Technologies (NYSE:A) with a Underweight recommendation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
|
T. Rowe Price Investment Management holds 9,968K shares representing 3.41% ownership of the company. VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,177K shares representing 3.14% ownership of the company. Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more.
|
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 9,177K shares representing 3.14% ownership of the company. In it's prior filing, the firm reported owning 12,057K shares, representing a decrease of 38.01%. In it's prior filing, the firm reported owning 8,219K shares, representing a decrease of 2.05%.
|
The projected annual revenue for Agilent Technologies is 7,130MM, an increase of 1.94%. Massachusetts Financial Services holds 11,037K shares representing 3.77% ownership of the company. T. Rowe Price Investment Management holds 9,968K shares representing 3.41% ownership of the company.
|
b6160bbf-87e2-417a-8536-0fddcbe0f2ee
|
40.0
|
2023-09-15 00:00:00 UTC
|
Notable Friday Option Activity: PRGS, POOL, A
|
A
|
https://www.nasdaq.com/articles/notable-friday-option-activity%3A-prgs-pool-a
|
nan
|
nan
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Progress Software Corp (Symbol: PRGS), where a total of 1,216 contracts have traded so far, representing approximately 121,600 underlying shares. That amounts to about 53.8% of PRGS's average daily trading volume over the past month of 226,140 shares. Particularly high volume was seen for the $50 strike put option expiring October 20, 2023, with 502 contracts trading so far today, representing approximately 50,200 underlying shares of PRGS. Below is a chart showing PRGS's trailing twelve month trading history, with the $50 strike highlighted in orange:
Pool Corp (Symbol: POOL) saw options trading volume of 1,502 contracts, representing approximately 150,200 underlying shares or approximately 53.3% of POOL's average daily trading volume over the past month, of 282,025 shares. Especially high volume was seen for the $360 strike put option expiring September 15, 2023, with 501 contracts trading so far today, representing approximately 50,100 underlying shares of POOL. Below is a chart showing POOL's trailing twelve month trading history, with the $360 strike highlighted in orange:
And Agilent Technologies, Inc. (Symbol: A) saw options trading volume of 8,847 contracts, representing approximately 884,700 underlying shares or approximately 52.8% of A's average daily trading volume over the past month, of 1.7 million shares. Particularly high volume was seen for the $130 strike call option expiring October 20, 2023, with 1,666 contracts trading so far today, representing approximately 166,600 underlying shares of A. Below is a chart showing A's trailing twelve month trading history, with the $130 strike highlighted in orange:
For the various different available expirations for PRGS options, POOL options, or A options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Funds Holding ATOM
CTCT Videos
Funds Holding RTNB
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $50 strike put option expiring October 20, 2023, with 502 contracts trading so far today, representing approximately 50,200 underlying shares of PRGS. Especially high volume was seen for the $360 strike put option expiring September 15, 2023, with 501 contracts trading so far today, representing approximately 50,100 underlying shares of POOL. Particularly high volume was seen for the $130 strike call option expiring October 20, 2023, with 1,666 contracts trading so far today, representing approximately 166,600 underlying shares of A.
|
Particularly high volume was seen for the $50 strike put option expiring October 20, 2023, with 502 contracts trading so far today, representing approximately 50,200 underlying shares of PRGS. Below is a chart showing PRGS's trailing twelve month trading history, with the $50 strike highlighted in orange: Pool Corp (Symbol: POOL) saw options trading volume of 1,502 contracts, representing approximately 150,200 underlying shares or approximately 53.3% of POOL's average daily trading volume over the past month, of 282,025 shares. Below is a chart showing POOL's trailing twelve month trading history, with the $360 strike highlighted in orange: And Agilent Technologies, Inc. (Symbol: A) saw options trading volume of 8,847 contracts, representing approximately 884,700 underlying shares or approximately 52.8% of A's average daily trading volume over the past month, of 1.7 million shares.
|
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Progress Software Corp (Symbol: PRGS), where a total of 1,216 contracts have traded so far, representing approximately 121,600 underlying shares. Below is a chart showing PRGS's trailing twelve month trading history, with the $50 strike highlighted in orange: Pool Corp (Symbol: POOL) saw options trading volume of 1,502 contracts, representing approximately 150,200 underlying shares or approximately 53.3% of POOL's average daily trading volume over the past month, of 282,025 shares. Below is a chart showing POOL's trailing twelve month trading history, with the $360 strike highlighted in orange: And Agilent Technologies, Inc. (Symbol: A) saw options trading volume of 8,847 contracts, representing approximately 884,700 underlying shares or approximately 52.8% of A's average daily trading volume over the past month, of 1.7 million shares.
|
Below is a chart showing PRGS's trailing twelve month trading history, with the $50 strike highlighted in orange: Pool Corp (Symbol: POOL) saw options trading volume of 1,502 contracts, representing approximately 150,200 underlying shares or approximately 53.3% of POOL's average daily trading volume over the past month, of 282,025 shares. Especially high volume was seen for the $360 strike put option expiring September 15, 2023, with 501 contracts trading so far today, representing approximately 50,100 underlying shares of POOL. Below is a chart showing A's trailing twelve month trading history, with the $130 strike highlighted in orange: For the various different available expirations for PRGS options, POOL options, or A options, visit StockOptionsChannel.com.
|
8df6c6dc-1e0c-4df3-8700-f25be40c3481
|
44.0
|
2023-09-05 00:00:00 UTC
|
Illumina names Agilent exec Jacob Thaysen as CEO
|
A
|
https://www.nasdaq.com/articles/illumina-names-agilent-exec-jacob-thaysen-as-ceo
|
nan
|
nan
|
Adds background in paragraphs 2-3
Sept 5 (Reuters) - Illumina Inc ILMN.O said on Tuesday its board has named Agilent Technologies' A.N executive Jacob Thaysen as the U.S. genetic testing company's CEO.
Thaysen would replace Charles Dadswell, who has been serving as Illumina's interim CEO since June.
The appointment comes months after Illumina's former CEO Francis deSouza stepped down, marking a victory for activist investor Carl Icahn.
Thaysen's appointment would become effective Sept. 25.
(Reporting by Manas Mishra and Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)
((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manaswrites15;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds background in paragraphs 2-3 Sept 5 (Reuters) - Illumina Inc ILMN.O said on Tuesday its board has named Agilent Technologies' A.N executive Jacob Thaysen as the U.S. genetic testing company's CEO. Thaysen would replace Charles Dadswell, who has been serving as Illumina's interim CEO since June. The appointment comes months after Illumina's former CEO Francis deSouza stepped down, marking a victory for activist investor Carl Icahn.
|
Thaysen would replace Charles Dadswell, who has been serving as Illumina's interim CEO since June. Thaysen's appointment would become effective Sept. 25. (Reporting by Manas Mishra and Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar) ((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manaswrites15;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds background in paragraphs 2-3 Sept 5 (Reuters) - Illumina Inc ILMN.O said on Tuesday its board has named Agilent Technologies' A.N executive Jacob Thaysen as the U.S. genetic testing company's CEO. The appointment comes months after Illumina's former CEO Francis deSouza stepped down, marking a victory for activist investor Carl Icahn. (Reporting by Manas Mishra and Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar) ((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manaswrites15;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds background in paragraphs 2-3 Sept 5 (Reuters) - Illumina Inc ILMN.O said on Tuesday its board has named Agilent Technologies' A.N executive Jacob Thaysen as the U.S. genetic testing company's CEO. Thaysen would replace Charles Dadswell, who has been serving as Illumina's interim CEO since June. The appointment comes months after Illumina's former CEO Francis deSouza stepped down, marking a victory for activist investor Carl Icahn.
|
551877a4-e207-45dc-8318-1e5b804da282
|
46.0
|
2023-08-31 00:00:00 UTC
|
Building Wealth with Spinoffs: How Adding These Gems Can Transform Your Portfolio
|
A
|
https://www.nasdaq.com/articles/building-wealth-with-spinoffs%3A-how-adding-these-gems-can-transform-your-portfolio
|
nan
|
nan
|
Imagine discovering a treasure map that leads to the chest containing the loot. Consider that the investment world has its own version of these concealed treasures: Spinoffs. These financial treasures have the potential to reshape your entire investment voyage, not just enhance your portfolio. The catch? You must look for them and do some work. A tough ask, I know.
What is A Spinoff?
In a Spinoff, a parent company separates one of its business entities or divisions into a standalone, independent company. By distributing shares of the spun-off company to the current proprietors of the parent, two separate publicly listed entities are created. The new enterprise that emerges because of a Spinoff is often referred to as a "Spinoff company." Spinoffs can increase shareholder value by allowing distinct companies to focus on their core competencies and releasing hidden value in specific business divisions. In addition, it offers investors the option to invest in various companies based on their investment preferences and risk tolerance. Or, alternatively, eradicate them.
The media frequently gets it wrong when speaking about Spinoffs. This is a very important point to remember. A ‘true’ Spinoff only happens when a share of a division is distributed amongst existing shareholders that own the parent company. Contrary to the media, IPOs, Divestitures, carve-outs, split-offs, and split-ups are not Spinoffs and consequently, these transactions lose many of the value creating dynamics of the Spinoff corporate action. Cross-reference information from various trustworthy sources, particularly official business communication. To fully comprehend the Spinoff and its ramifications, investors should also look for information from reliable financial analysts, subject-matter experts, and formal regulatory filings, such as those with the Securities and Exchange Commission (SEC).
Do Spinoffs Outperform?
The “Spinoff” is an essentially inefficient method for distributing stock to the incorrect individuals. You receive shares whether you desire them or not. Typically, investors acquire these shares by default and sell them on the open market almost immediately, making them inexpensive companies that no one is interested in. They are occasionally referred to as "orphan securities." At this point, X marks the location, and digging should commence.
Why the dynamics of Spinoffs make it an essential area for an investor to analyze:
Studies have shown that Spinoffs have historically beaten the market by over 10 percent as the pure, newly focused business takes off.
Compensation for executives can be more closely correlated with business performance. The company will become smaller, which will increase the executives' motivation and sense of ownership.
Separating companies allows each entity to be properly valued and can sometimes unlock a “conglomerate discount."
Due to the likelihood that the company would be small and lack a roadshow, it is under-followed. As a result, there are more chances for investors to discover returns greater than the index.
The Edge Consulting Groups 20 year study shows that Spinoffs are likely to be taken over. Roughly 35 percent are acquired around the two-year mark post-Spinoff.
Typically, there are hundreds of Spinoff situations a year. Around 40 have over $1 billion in market cap. This is a sweet spot where liquidity and “real” companies come together in my opinion.
5 Reasons Why You Should Be Looking For These Situations
Including Spinoffs in your investment portfolio can provide a variety of benefits, including diversification, undervalued opportunities, and the potential for higher returns and enhanced performance.
1. Enhanced Diversification: Incorporating Spinoffs introduces a new layer of diversification. Since Spinoff companies often operate in different sectors than their parent companies, they can provide exposure to industries that might not have been represented in your portfolio. This helps spread risk and reduces the impact of negative events within a specific sector.
2. Undervalued Opportunities: Spinoffs are sometimes overlooked by the market, leading to potential undervaluation. This presents an opportunity for investors to purchase shares of promising companies at a lower price compared to their intrinsic value. As the market gradually recognizes their worth, these undervalued gems can yield substantial returns.
3. Focused Management: Spinoff companies can streamline operations and focus on their core competencies, which often leads to improved efficiency and performance. The management teams of these newly independent entities tend to be more agile and dedicated to the success of their specific business, potentially translating into better growth prospects.
4. Catalyst for Change: The newfound independence of a Spinoff can lead to strategic changes, such as cost-cutting initiatives, innovation, and targeted expansion plans. These changes can drive improved financial performance and boost shareholder value over time.
5. Potential for Outperformance: Historical data indicates that Spinoffs often outperform the broader market indices. This outperformance can be attributed to a combination of factors, including improved focus, better capital allocation decisions, and the market's eventual recognition of the Spinoff's value proposition.
Why isn’t Everybody Looking At Them?
I asked the legendary investor Joel Greenblatt this question once and he didn’t hesitate to give me the answer. ‘No one wants to do the work.’ Spinoffs analysis takes a lot of effort and, surprise, surprise, not many want to do it. However, as an investment veteran of over 30 years, I can categorically say that some of my most profitable ideas come from doing a hell of a lot of work and finding the angle and edge in the situation in this area. Furthermore, they are not promoted by brokers. Unlike an IPO there is no stock to sell you. You gain the Spinoff from holding the parent company whether you like it or not. This opens a whole range of dynamics that are interesting for investing.
Recent Spinoffs That You May Know
AbbVie (ABBV) (formerly known as Abbott Laboratories' biopharmaceutical business) was spun off from Abbott Laboratories in 2013. AbbVie has outperformed the S&P 500 by more than 200% since the spinoff.
Visa (V) was spun off from Bank of America (BAC) in 2008. Visa has outperformed the S&P 500 by more than 400% since Spinoff.
Mastercard (MA) was spun off from American Express (AXP) in 2006. Mastercard has outperformed the S&P 500 by more than 300% since Spinoff.
Agilent Technologies (A) was spun off from Hewlett-Packard (HPQ) in 1999. Agilent Technologies has outperformed the S&P 500 by more than 200% since the spinoff.
Johnson & Johnson's (JNJ) Life Sciences division was spun off as a separate company called Janssen Pharmaceutical Companies in 2017. Janssen Pharmaceutical Companies has outperformed the S&P 500 by more than 50% since the spinoff.
These are just a few examples of successful stock Spinoffs. There are many other examples, and the success of a spinoff can vary depending on several factors, such as the underlying business, the management team, and the market condition.
In Summary
If you are after hidden value where no one else is looking, look no further than this area of the market. There are services out there that can help, but ultimately a little hard work in a proven area will get you to some positive wealth creation a lot faster than competing with the masses.
On the date of publication, Jim Osman did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
To fully comprehend the Spinoff and its ramifications, investors should also look for information from reliable financial analysts, subject-matter experts, and formal regulatory filings, such as those with the Securities and Exchange Commission (SEC). The management teams of these newly independent entities tend to be more agile and dedicated to the success of their specific business, potentially translating into better growth prospects. This outperformance can be attributed to a combination of factors, including improved focus, better capital allocation decisions, and the market's eventual recognition of the Spinoff's value proposition.
|
Why the dynamics of Spinoffs make it an essential area for an investor to analyze: Studies have shown that Spinoffs have historically beaten the market by over 10 percent as the pure, newly focused business takes off. 5 Reasons Why You Should Be Looking For These Situations Including Spinoffs in your investment portfolio can provide a variety of benefits, including diversification, undervalued opportunities, and the potential for higher returns and enhanced performance. Focused Management: Spinoff companies can streamline operations and focus on their core competencies, which often leads to improved efficiency and performance.
|
In a Spinoff, a parent company separates one of its business entities or divisions into a standalone, independent company. The new enterprise that emerges because of a Spinoff is often referred to as a "Spinoff company." Why the dynamics of Spinoffs make it an essential area for an investor to analyze: Studies have shown that Spinoffs have historically beaten the market by over 10 percent as the pure, newly focused business takes off.
|
What is A Spinoff? In a Spinoff, a parent company separates one of its business entities or divisions into a standalone, independent company. Typically, investors acquire these shares by default and sell them on the open market almost immediately, making them inexpensive companies that no one is interested in.
|
a33f1c8a-6b97-4779-b619-ec0f8effbb7b
|
49.0
|
2023-08-21 00:00:00 UTC
|
Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble
|
A
|
https://www.nasdaq.com/articles/buy-the-drop%3A-3-stocks-to-snag-after-this-months-20-tumble
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
August has been a great month for investors looking for bargain stocks to buy on the dip. The S&P 500, Dow Jones Industrial Average, and the Nasdaq 100 were down 2,1%, 2.0%, and 2.4%, respectively, for the week of Aug. 14-18. Barron’s believes that September could be worse. If the past week is any indication, they could be on to something.
Fundstrat analyst Tom Lee thinks August has been its typical mercurial self where gains are hard to come by and that the good times should return soon. Baron’s reported Lee’s comments from his Aug. 18 note to clients:
“[T]he month’s declines haven’t shaken Lee’s core bullish thesis. ‘We see this more as ‘it’s August’ rather than the start of a larger rout…we are not in the camp this spills over into a wider selloff. That could happen, but more bad things need to emerge. In fact, there are some signs that we could see the stocks begin to stabilize soon.’”
So, if you’re a risk-averse investor, you might want to wait a couple of weeks to see if the markets bottom.
In the meantime, a quick screen of S&P 500 stocks down more than 20% over the past month gives bargain-hunting investors 14 stocks to choose from. Here are three undervalued due to their 20%, including one name from three different sectors.
Sealed Air (SEE)
Source: Shutterstock
Sealed Air (NYSE:SEE) represents the materials sector. Its stock is down 25% for the past month and 31% year-to-date.
Analysts are moderately optimistic about the stock, with 7 of the 15 rating it as Overweight or an outright Buy. It’s target price is $45 which is 31% higher than its current share price.
One of the things that I use to assess value is free cash flow yield. If it’s over 8%, it’s definitely value. Between 4% and 8%, it’s reasonable value, if not dirt cheap. In the trailing 12 months ended June 30, its free cash flow was $152 million. Based on an enterprise value of $9.78 billion, it has a free cash flow yield of 1.6%, which suggests it’s not cheap.
Before you toss the company best known for bubble wrap packaging overboard, consider its historical FCF yield. In 2020, it had a free cash flow of $556 million. Based on an enterprise value of $10.6 billion. At first glance, it appears Sealed Air’s business has deteriorated.
And to a certain extent, it has, which is why it’s moving forwqard with SEE 2.0. This revitalization plan should deliver $150 million in annual cost savings by the end of 2025 and a return to its historical earnings and sales growth in 2024.
Its stock hasn’t been this low since June 2020. Get ready for a revival in the waning months of 2023 and into 2024.
Keysight Technologies (KEYS)
Source: fantasyform/Shutterstock.com
Keysight Technologies (NYSE:KEYS) represents the tech sector. Its stock is down 23% for the past month and 24% year-to-date. Like Sealed Air, it hasn’t traded this low since 2020.
Keysight is a relatively new company by S&P 500 standards, incorporated in 2013. However, its history dates back to 1939 and Hewlett-Packard’s founding by Bill Hewlett and Dave Packard. Their first product was an audio oscillator. Electronic measurement was their business.
In 1999, Agilent Technologies (NYSE:A) was formed to operate HP’s Medical Products and Instrument Group. In 2013, Agilent was split into two pure-play electronic measurement companies. Keysight was the one of the two, going public on November 1, 2014 after separating from Agilent. Agilent shareholders got one share of Keysight for two held by the parent.
KEYS stock is up 335% since it began trading in November 2014. Agilent is up 191% over the same period.
Shares have lost their mojo recently because the company reported Q3 2023 results on August 18th that included a downward revision of its guidance. It now expects fourth-quarter sales and earnings to decline by 10% and 13%, respectively.
Currently trading at 4.16x sales — less than its five-year average of 5.1x — its enterprise value of $22.5 billion is 12.87x its earnings before interest, taxes, depreciation and amortization (EBITDA). That’s lower than it’s been since 2016.
ResMed (RMD)
Source: Vitalii Vodolazskyi / Shutterstock
ResMed (NYSE:RMD) represents the healthcare sector. Its stock is down 25% for the past month and 21% year-to-date. Like the other two, it hasn’t traded this low since 2020.
Interestingly, ResMed’s business is probably doing the best in terms of top-line growth among the trio, up 23% in Q4 2023 and 18% for all of 2023 to $4.2 billion. However, investors began to abandon the stock after hearing its gross margin (56.5%) and operating margin (29.0%) dropped for the year.
All of its stock losses in 2023 are post-earnings. Investors have rightly or wrongly decided that the contraction of its margins in light of double-digit revenue growth suggests the quality of the sales increase for the maker of sleep apnea equipment is suspect.
ResMed CEO Mick Farrell is very confident about the future. He stated in the Q4 2023 conference call:
“Patient demand continues to drive increased adoption and utilization of our mask resupply programs, augmenting a steady cadence of new patient setups. We continue to see strong growth in both the U.S. business where provider resupply programs have augmented growth and in our markets outside the U.S. where our consumer outreach and subscription programs are also driving mass replenishment directly with those end user patients.”
Of the 24 analysts covering the stock, 18 rate it Overweight or an outright Buy with a $240 median price, 45% higher than its current share price.
I see ResMed as the best long-term hold of the trio, although all three should make you money over 3-5 years.
On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Will Ashworth has written about investments full-time since 2008. Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Investors have rightly or wrongly decided that the contraction of its margins in light of double-digit revenue growth suggests the quality of the sales increase for the maker of sleep apnea equipment is suspect. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble appeared first on InvestorPlace.
|
Sealed Air (SEE) Source: Shutterstock Sealed Air (NYSE:SEE) represents the materials sector. Keysight Technologies (KEYS) Source: fantasyform/Shutterstock.com Keysight Technologies (NYSE:KEYS) represents the tech sector. We continue to see strong growth in both the U.S. business where provider resupply programs have augmented growth and in our markets outside the U.S. where our consumer outreach and subscription programs are also driving mass replenishment directly with those end user patients.” Of the 24 analysts covering the stock, 18 rate it Overweight or an outright Buy with a $240 median price, 45% higher than its current share price.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips August has been a great month for investors looking for bargain stocks to buy on the dip. In the meantime, a quick screen of S&P 500 stocks down more than 20% over the past month gives bargain-hunting investors 14 stocks to choose from. We continue to see strong growth in both the U.S. business where provider resupply programs have augmented growth and in our markets outside the U.S. where our consumer outreach and subscription programs are also driving mass replenishment directly with those end user patients.” Of the 24 analysts covering the stock, 18 rate it Overweight or an outright Buy with a $240 median price, 45% higher than its current share price.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips August has been a great month for investors looking for bargain stocks to buy on the dip. Keysight was the one of the two, going public on November 1, 2014 after separating from Agilent. Interestingly, ResMed’s business is probably doing the best in terms of top-line growth among the trio, up 23% in Q4 2023 and 18% for all of 2023 to $4.2 billion.
|
0b5501ab-016d-49c1-97a9-b98e10b464f0
|
50.0
|
2023-08-18 00:00:00 UTC
|
These 3 Unusually Active Options Have 1 Thing in Common
|
A
|
https://www.nasdaq.com/articles/these-3-unusually-active-options-have-1-thing-in-common
|
nan
|
nan
|
As I write this, it’s approaching noon Friday on the east coast. The major indexes are either down or flat on the day. Stocks appear headed for their worst week since March.
Investors are worried about many subjects, including further interest rate hikes, higher bond yields, and a faltering Chinese economy.
While I can’t promise you a rose garden regarding these subjects, I can tell you that it can always be worse. Think March 2009 or March 2020.
My task on Fridays is to discuss unusual options activities that I find particularly interesting. The three options that have caught my attention today have one thing in common.
By the end, you ought to know what it is.
Happy Weekend!
Agilent Technologies
The first to catch my attention involves selling Agilent Technologies (A) put options. As I write this, one put and one call exhibits unusual options activity. While the call gives you a low ask price, I'm going with the Nov. 17 $115 put.
The bid price on this Agilent put is $3.70. Based on a share price of $119.63, we’re looking at an annualized yield of 12.4%. With 91 days to expiry, the volume is 828, or 2.55x open interest.
Currently, $4.63 above the strike, there is a real possibility that the put buyer will make you buy the shares at the strike. In that case, you’re not losing money until it falls to $111.30.
Over the past year, Agilent stock hasn’t traded that low, with a 52-week low of $113.28. The last time its shares consistently traded below $111 was in late 2020.
The odds are good that it might hit $115, but $111.30 is much less likely. I’m no technical analysis guru, but it does appear its shares bottomed in June.
I know what you’re thinking: Didn’t the company give its guidance on China concerns? It sure did.
On Wednesday, it said it expects revenue of $6.80 billion for its fiscal year, down from its previous guidance of $6.93 billion. On the bottom line, its earnings per share estimate has dropped by 20 cents to $5.40 at the low end of its guidance.
There you have it: approximately $130 million less revenue and 20 cents per share. The EPS estimate revision translates to less than a 4% cut in earnings.
Currently trading at 22.5x earnings, the maker of lab instruments is in value territory. Having traded near $180 as recently as September 2021, this is a good entry point.
Ford
Another stock that’s fallen out of favor with investors is Ford (F). Its shares are down 26% over the past year. Investors might be skeptical about its electric vehicle plans.
On Aug. 17, it announced that it and a consortium of companies would invest $887 million to build a plant in Becancour, Quebec, to produce EV battery materials. When the plant gets up to speed, it will be capable of producing 45,000 tonnes of cathode active materials (CAM).
“This cathode facility will supply the material that goes into Ford’s future EVs in North America, specifically some of our future trucks,” Lisa Drake, Ford vice president for EVs, told reporters.
As part of the investment, the Canadian government will make a CAD$322 million condition loan, while the Quebec government will kick in a similar amount on a forgivable basis. The plant’s expected to open in 2026.
I mention this because Ford recently reported healthy Q2 2023 earnings of $1.9 billion, a three-fold increase from a year ago. However, the iconic Detroit automaker said its EV business lost $1.1 billion on an EBIT basis during the quarter, more than double its loss in Q2 2022. In 2023, it expects EBIT losses of $4.5 billion, $1.5 billion more than expected.
Ford isn’t alone here.
Almost every company with a presence in EVs is losing money and ratcheting their production outputs lower to recognize that the uptake by consumers, especially in North America, will be slower than anticipated.
As soon as the charging networks are up to snuff in North America, EV production will rocket higher. It will take patience from investors.
The put to sell is the Sept. 8 $12 strike with a bid price of $0.38 for a net price of $11.62. That’s an annualized yield of 55.6% should its share price fail to remain under $12 by September.
With a 52-week low of $10.90, you aren’t likely to lose much on the trade, even if it falls into the low $11s. Long-term, Ford’s going to be a player in EVs.
U.S. Steel
The iconic but oft-struggled U.S. steelmaker is possibly in the final throes of being sold to one of its competitors. Who it will be, we still don’t know. However, one thing is sure: U.S. Steel’s (X) final sale price will increase.
Cleveland-Cliffs (CLF) has already offered $35 in cash and stock. That was rejected. Privately held Esmark has also made an unsolicited bid that’s been rejected by the company.
Where this goes is anyone’s guess.
However, if you sell the Aug. 25 $28.50 put, you’re looking at an annualized yield of almost 20%, with virtually no chance you’ll be asked to buy the shares. Keep selling puts weekly at a sub-$30 strike until the deal is done.
Sure, if everything goes away and there is no sale, the stock price could crater into the $20s, but by then, you might have rolled the dice on three or four occasions, pocketing more than enough premium income to account for any decline.
Consider this my M&A arbitrage bet.
Have you figured out the one thing these three stocks have in common? They all have single-letter stock symbols.
More Options News from Barchart
Walmart's Better Than Expected Earnings and FCF Could Push WMT Stock Higher Here’s the Real Lowdown of Ross Stores’ (ROST) Q2 Report Somebody Really Must Like Suncor Given Its Unusual Options Activity Attention Speculators: Going Long Discover Financial Services (DFS) Might Not Be a Bad Idea
On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Investors are worried about many subjects, including further interest rate hikes, higher bond yields, and a faltering Chinese economy. Almost every company with a presence in EVs is losing money and ratcheting their production outputs lower to recognize that the uptake by consumers, especially in North America, will be slower than anticipated. More Options News from Barchart Walmart's Better Than Expected Earnings and FCF Could Push WMT Stock Higher Here’s the Real Lowdown of Ross Stores’ (ROST) Q2 Report Somebody Really Must Like Suncor Given Its Unusual Options Activity Attention Speculators: Going Long Discover Financial Services (DFS) Might Not Be a Bad Idea On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article.
|
Agilent Technologies The first to catch my attention involves selling Agilent Technologies (A) put options. Over the past year, Agilent stock hasn’t traded that low, with a 52-week low of $113.28. On Aug. 17, it announced that it and a consortium of companies would invest $887 million to build a plant in Becancour, Quebec, to produce EV battery materials.
|
Over the past year, Agilent stock hasn’t traded that low, with a 52-week low of $113.28. “This cathode facility will supply the material that goes into Ford’s future EVs in North America, specifically some of our future trucks,” Lisa Drake, Ford vice president for EVs, told reporters. More Options News from Barchart Walmart's Better Than Expected Earnings and FCF Could Push WMT Stock Higher Here’s the Real Lowdown of Ross Stores’ (ROST) Q2 Report Somebody Really Must Like Suncor Given Its Unusual Options Activity Attention Speculators: Going Long Discover Financial Services (DFS) Might Not Be a Bad Idea On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article.
|
On the bottom line, its earnings per share estimate has dropped by 20 cents to $5.40 at the low end of its guidance. “This cathode facility will supply the material that goes into Ford’s future EVs in North America, specifically some of our future trucks,” Lisa Drake, Ford vice president for EVs, told reporters. The put to sell is the Sept. 8 $12 strike with a bid price of $0.38 for a net price of $11.62.
|
c5785ecd-d558-4823-8918-13eb047d302d
|
66.0
|
2023-08-15 00:00:00 UTC
|
Agilent Technologies cuts annual forecasts on China weakness
|
A
|
https://www.nasdaq.com/articles/agilent-technologies-cuts-annual-forecasts-on-china-weakness
|
nan
|
nan
|
By Pratik Jain
Aug 15 (Reuters) - Medical equipment maker Agilent Technologies A.N cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery.
Agilent expects full-year revenue to be between $6.80 billion and $6.85 billion, compared with $6.93 billion to $7.03 billion projected earlier.
It expects annual adjusted profit per share between $5.40 and $5.43, compared with its prior forecast of $5.60 to $5.65.
"In July, we saw a further (sales) deterioration in China, resulting in the 17% decline for the quarter," CFO Robert McMahon said in a post-earnings call.
"While the Q3 decline in China was centered in pharma, which was down 30%, we did see weakness in other end markets as well. We expect the conditions we've seen in July to persist in China for Q4."
For the third quarter ended July 31, the company's total sales fell 2.7% to $1.67 billion.
Sales from its third-largest segment that offers genetic sequencing, contract manufacturing, research and development, among others, were $349 million, missing a Refinitiv estimate of $355.67 million.
The sales miss was due to softness in genomics and the shutdown of its Resolution Bioscience business, which offered next-generation sequencing-based cancer diagnostics solutions.
The company said on Tuesday it has taken a $291 million pre-tax charge in the quarter associated with the shutdown and expects the wind-down to continue through the fourth quarter and into early fiscal 2024.
Agilent CEO Mike McMullen flagged performance of its largest unit that provides laboratory instruments, consumables and software continues to be affected by the market environment in China.
"Our sales funnel remains healthy and are up year-on-year, but deal velocity continues to slow as customers remain cautious in making capital purchases," McMullen added.
Its quarterly adjusted profit per share was $1.43, above expectations of $1.36.
(Reporting by Pratik Jain in Bengaluru; Editing by Shilpi Majumdar)
((Pratik.Jain@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Pratik Jain Aug 15 (Reuters) - Medical equipment maker Agilent Technologies A.N cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery. The sales miss was due to softness in genomics and the shutdown of its Resolution Bioscience business, which offered next-generation sequencing-based cancer diagnostics solutions. Agilent CEO Mike McMullen flagged performance of its largest unit that provides laboratory instruments, consumables and software continues to be affected by the market environment in China.
|
By Pratik Jain Aug 15 (Reuters) - Medical equipment maker Agilent Technologies A.N cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery. It expects annual adjusted profit per share between $5.40 and $5.43, compared with its prior forecast of $5.60 to $5.65. For the third quarter ended July 31, the company's total sales fell 2.7% to $1.67 billion.
|
By Pratik Jain Aug 15 (Reuters) - Medical equipment maker Agilent Technologies A.N cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery. Agilent expects full-year revenue to be between $6.80 billion and $6.85 billion, compared with $6.93 billion to $7.03 billion projected earlier. The company said on Tuesday it has taken a $291 million pre-tax charge in the quarter associated with the shutdown and expects the wind-down to continue through the fourth quarter and into early fiscal 2024.
|
It expects annual adjusted profit per share between $5.40 and $5.43, compared with its prior forecast of $5.60 to $5.65. "In July, we saw a further (sales) deterioration in China, resulting in the 17% decline for the quarter," CFO Robert McMahon said in a post-earnings call. For the third quarter ended July 31, the company's total sales fell 2.7% to $1.67 billion.
|
a7598127-fd7e-40d8-bd2b-c2f0d9b33604
|
98.0
|
2023-05-24 00:00:00 UTC
|
Why Agilent Technologies Stock Is Sinking Today
|
A
|
https://www.nasdaq.com/articles/why-agilent-technologies-stock-is-sinking-today
|
nan
|
nan
|
What happened
Shares of Agilent Technologies (NYSE: A) were sinking 7.9% lower as of 11:34 a.m. ET on Wednesday. The decline came after the life sciences company announced its fiscal 2023 second-quarter results following the market close on Tuesday.
Agilent reported fiscal Q2 revenue of $1.72 billion, up 6.8% year over year. It posted net income of $302 million, or $1.02 per share, based on generally accepted accounting principles (GAAP). The company's non-GAAP earnings were $377 million, or $1.27 per share.
Although Agilent narrowly topped the consensus Wall Street earnings estimate for the latest quarter, the company's guidance fell short.
Agilent projects fiscal Q3 revenue of between $1.64 billion and $1.675 billion. Analysts' average third-quarter revenue estimate is $1.77 billion. The company expects fiscal Q3 non-GAAP earnings per share of $1.36 to $1.38, lower than the consensus estimate of $1.43.
The company's full-year outlook also disappointed investors. Agilent forecasts full-year revenue of between $6.93 billion and $7.03 billion. Analysts' average revenue estimate is $7.57 billion. Agilent expects full-year non-GAAP earnings per share of $5.60 to $5.65. The consensus estimate is $6.29.
So what
Agilent attributed its lower-than-expected guidance to "increased market uncertainties." CEO Mike McMullen also pointed to the "increasingly challenging market environment."
The main problems for the company are largely beyond its control. McMullen noted in Agilent's quarterly conference call that "continued macroeconomic uncertainty coupled with stresses in the banking system have accelerated a more conservative approach from our customers."
Now what
Agilent remains in solid financial shape to weather its current headwinds. The company should be able to deliver stronger growth once the economy gets on a firmer footing.
10 stocks we like better than Agilent Technologies
When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Agilent Technologies wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of May 22, 2023
Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
It posted net income of $302 million, or $1.02 per share, based on generally accepted accounting principles (GAAP). Although Agilent narrowly topped the consensus Wall Street earnings estimate for the latest quarter, the company's guidance fell short. McMullen noted in Agilent's quarterly conference call that "continued macroeconomic uncertainty coupled with stresses in the banking system have accelerated a more conservative approach from our customers."
|
The company expects fiscal Q3 non-GAAP earnings per share of $1.36 to $1.38, lower than the consensus estimate of $1.43. Analysts' average revenue estimate is $7.57 billion. Agilent expects full-year non-GAAP earnings per share of $5.60 to $5.65.
|
Agilent projects fiscal Q3 revenue of between $1.64 billion and $1.675 billion. The company expects fiscal Q3 non-GAAP earnings per share of $1.36 to $1.38, lower than the consensus estimate of $1.43. 10 stocks we like better than Agilent Technologies When our analyst team has a stock tip, it can pay to listen.
|
The company's non-GAAP earnings were $377 million, or $1.27 per share. The company expects fiscal Q3 non-GAAP earnings per share of $1.36 to $1.38, lower than the consensus estimate of $1.43. 10 stocks we like better than Agilent Technologies When our analyst team has a stock tip, it can pay to listen.
|
17af9b6f-c926-4a70-bbbd-8dbda903f6bf
|
108.0
|
2023-05-24 00:00:00 UTC
|
Agilent Technologies Slips After KeyBanc Downgrade
|
A
|
https://www.nasdaq.com/articles/agilent-technologies-slips-after-keybanc-downgrade
|
nan
|
nan
|
(RTTNews) - Agilent Technologies, Inc. (A) shares are sliding more than 11 percent on Wednesday morning trade after investment advisory KeyBanc downgraded the company to Sector Weight from Overweight, despite earnings growth in the second quarter.
Currently, shares are at $114.12, down 11.21 percent from the previous close of $128.64 on a volume of 833,531.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies, Inc. (A) shares are sliding more than 11 percent on Wednesday morning trade after investment advisory KeyBanc downgraded the company to Sector Weight from Overweight, despite earnings growth in the second quarter. Currently, shares are at $114.12, down 11.21 percent from the previous close of $128.64 on a volume of 833,531. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies, Inc. (A) shares are sliding more than 11 percent on Wednesday morning trade after investment advisory KeyBanc downgraded the company to Sector Weight from Overweight, despite earnings growth in the second quarter. Currently, shares are at $114.12, down 11.21 percent from the previous close of $128.64 on a volume of 833,531. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies, Inc. (A) shares are sliding more than 11 percent on Wednesday morning trade after investment advisory KeyBanc downgraded the company to Sector Weight from Overweight, despite earnings growth in the second quarter. Currently, shares are at $114.12, down 11.21 percent from the previous close of $128.64 on a volume of 833,531. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies, Inc. (A) shares are sliding more than 11 percent on Wednesday morning trade after investment advisory KeyBanc downgraded the company to Sector Weight from Overweight, despite earnings growth in the second quarter. Currently, shares are at $114.12, down 11.21 percent from the previous close of $128.64 on a volume of 833,531. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
03e8f8c0-12be-4ce6-bb17-39481138e242
|
122.0
|
2023-05-19 00:00:00 UTC
|
Will Solid Top-Line Growth Buoy Workday's (WDAY) Q1 Earnings?
|
A
|
https://www.nasdaq.com/articles/will-solid-top-line-growth-buoy-workdays-wday-q1-earnings
|
nan
|
nan
|
Workday, Inc. WDAY is scheduled to report first-quarter fiscal 2024 results on May 25, after the market closes. In the last reported quarter, the company delivered an earnings surprise of 11.2%. It pulled off a trailing four-quarter earnings surprise of 7.7%, on average.
The Pleasanton, CA-based firm is likely to have recorded higher revenues in the fiscal first quarter on a year-over-year basis, driven by its approach of continuous innovation and healthy demand for its applications for finance and human resources.
Factors at Play
In the fiscal first quarter, The Amenity Collective deployed a bevy of Workday solutions to break down data silos and drive efficiencies to accelerate its business transformation. These included Workday Financial Management, Workday Human Capital Management, Workday Payroll and Workday Learning. The transition to a cloud-based system to unify the lifestyle services and hospitality firm’s data into a single platform and drive front and back-office operations across the full breadth of the businesses is likely to have generated incremental revenues for Workday in the quarter.
During the to-be-reported quarter, EZCORP, Inc. selected several Workday solutions to improve its real-time visibility into costs and revenue drivers. These included Workday Financial Management, Workday Human Capital Management, Workday Adaptive Planning, Workday Strategic Sourcing and Workday Accounting Center. The solutions are likely to have helped the leading provider of pawn transactions to fast-track its digital transformation efforts for improved decision-making. This is likely to be reflected in the upcoming quarterly results.
For the April quarter, the Zacks Consensus Estimate for revenues is pegged at $1,675 million, which indicates growth from the year-ago quarter’s reported figure of $1,435 million. The consensus estimate for adjusted earnings per share is pegged at $1.10, suggesting an increase from 83 cents reported in the prior year.
Earnings Whispers
Our proven model does not predict an earnings beat for Workday for the fiscal first quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here.
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is -9.49%, with the former pegged at $1.00 and the latter at $1.10. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Workday, Inc. Price and EPS Surprise
Workday, Inc. price-eps-surprise | Workday, Inc. Quote
Zacks Rank: Workday currently has a Zacks Rank #2.
Stocks to Consider
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
HP Inc. HPQ is set to release quarterly numbers on May 30. It has an Earnings ESP of +2.29% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Earnings ESP for Agilent Technologies, Inc. A is +0.40% and it carries a Zacks Rank of 3. The company is scheduled to report quarterly numbers on May 23.
The Earnings ESP for Jabil Inc. JBL is +3.38% and it carries a Zacks Rank of 3. The company is scheduled to report quarterly numbers on Jun 15.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HP Inc. (HPQ) : Free Stock Analysis Report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Jabil, Inc. (JBL) : Free Stock Analysis Report
Workday, Inc. (WDAY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The Pleasanton, CA-based firm is likely to have recorded higher revenues in the fiscal first quarter on a year-over-year basis, driven by its approach of continuous innovation and healthy demand for its applications for finance and human resources. Factors at Play In the fiscal first quarter, The Amenity Collective deployed a bevy of Workday solutions to break down data silos and drive efficiencies to accelerate its business transformation. The transition to a cloud-based system to unify the lifestyle services and hospitality firm’s data into a single platform and drive front and back-office operations across the full breadth of the businesses is likely to have generated incremental revenues for Workday in the quarter.
|
These included Workday Financial Management, Workday Human Capital Management, Workday Payroll and Workday Learning. These included Workday Financial Management, Workday Human Capital Management, Workday Adaptive Planning, Workday Strategic Sourcing and Workday Accounting Center. Click to get this free report HP Inc. (HPQ) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Jabil, Inc. (JBL) : Free Stock Analysis Report Workday, Inc. (WDAY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
These included Workday Financial Management, Workday Human Capital Management, Workday Adaptive Planning, Workday Strategic Sourcing and Workday Accounting Center. Workday, Inc. Price and EPS Surprise Workday, Inc. price-eps-surprise | Workday, Inc. Quote Zacks Rank: Workday currently has a Zacks Rank #2. Click to get this free report HP Inc. (HPQ) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Jabil, Inc. (JBL) : Free Stock Analysis Report Workday, Inc. (WDAY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In the last reported quarter, the company delivered an earnings surprise of 11.2%. The company is scheduled to report quarterly numbers on May 23. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
|
d2b91b98-07f0-478f-bde7-b6040fd3fc16
|
135.0
|
2023-05-15 00:00:00 UTC
|
Semtech's (SMTC) New Deal Boosts LoRa Technology Adoption
|
A
|
https://www.nasdaq.com/articles/semtechs-smtc-new-deal-boosts-lora-technology-adoption
|
nan
|
nan
|
Semtech Corporation SMTC is winning partnerships on the back of robust LoRa solutions.
This is evident from the recent selection of LoRa-enabled sensors and LoRaWAN-based gateways by Sustainable Hrvest Sdn Bhd. This reflects the efficiency and reliability of Semtech’s LoRa technology.
Further, it boosts adoption as well as the customer base of its LoRa technology.
Notably, Sustainable Hrvest Sdn Bhd has deployed LoRa sensors and LoRaWAN gateways across its Durian fruit farms in Malaysia.
The sensors provide farmers with real-time data on the health of their farms at every stage of the growth cycle, from pre-harvest to post-harvest, allowing for more efficient and productive farming practices, reduced operational costs and increased crop yields.
The LoRa chipsets connect sensors to the cloud and enable real-time communication of data and analytics, helping to enhance the efficiency and productivity of sustainable IoT use cases.
There are currently 30 LoRa-powered farms in Malaysia, with new plantations expected to go live in the coming year.
Semtech Corporation Price and Consensus
Semtech Corporation price-consensus-chart | Semtech Corporation Quote
Growth Prospects
The company’s current move positions it well to capitalize on the growth prospects present in the global agriculture market.
Per a report from The Business Research Company, the underlined market is expected to hit $19,007.8 billion by 2027, witnessing a CAGR of 9.1% between 2023 and 2027.
A report from Research and Markets states that the global agriculture market is expected to grow to $18,814.21 billion at a CAGR of 10.7% between 2022 and 2026.
We believe that Semtech’s growing footprint in this promising market will help it win investors’ confidence in the days ahead.
Coming to the price performance, SMTC has declined 35.6% in the year-to-date period against the industry’s rise of 9.3%.
Portfolio Strength: Key Catalyst
Semtech’s constant efforts toward expanding its product portfolio are expected to continue aiding it in gaining momentum across new customers and sustaining the existing ones.
Recently, the company introduced the PerSe Connect SX9376 chipset, which enables RF performance optimization, improved connectivity and compliance with global specific absorption rate regulations for 5G-enabled consumer products.
Additionally, SMTC announced the release of the first LoRa-enabled third-party devices based on Amazon Sidewalk, which will raise demand for LoRa-enabled development kits and modules and reinforce Semtech's position as a leading technology provider for IoT connection.
Semtech also introduced a transceiver, namely LoRa Connect LR1121, which features low power consumption, the LoRaWAN standard, as well as global connectivity. It is ideal for use in Internet of Things (IoT) endpoints.
We note that expanding portfolio strength is expected to aid the company’s performance across the various end markets.
However, weak demand environments across the end markets are a major concern. Macroeconomic headwinds, including export restrictions, inflationary pressure and supply-chain constraints, remain overhangs for Semtech.
Zacks Rank and Stocks to Consider
Currently, Semtech carries a Zacks Rank #4 (Sell).
Investors interested in the broader Zacks Computer & Technology sector can consider some better-ranked stocks like Agilent Technologies A, DigitalOcean DOCN and AMETEK AME. Agilent Technologies, DigitalOcean and AMETEK each carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Agilent Technologies shares have gained 9.2% in the past year. The Zacks Consensus Estimate for A’s second-quarter fiscal 2023 earnings is pegged at $1.27 per share, suggesting an increase of 12.4% from the prior-year quarter’s reported figure.
DigitalOcean shares have risen 2.2% in the past year. The Zacks Consensus Estimate for DOCN’s second-quarter earnings is pegged at 38 cents per share, suggesting a jump from 20 cents per share reported in the prior-year quarter.
AMETEK shares have rallied 19.5% in the past year. The Zacks Consensus Estimate for AME’s second-quarter earnings is pegged at $1.50 per share, suggesting an increase of 8.7% from the prior-year quarter’s reported figure.
This Little-Known Semiconductor Stock Could Be Your Portfolio’s Hedge Against Inflation
Everyone uses semiconductors. But only a small number of people know what they are and what they do. If you use a smartphone, computer, microwave, digital camera or refrigerator (and that’s just the tip of the iceberg), you have a need for semiconductors. That’s why their importance can’t be overstated and their disruption in the supply chain has such a global effect. But every cloud has a silver lining. Shockwaves to the international supply chain from the global pandemic have unearthed a tremendous opportunity for investors. And today, Zacks' leading stock strategist is revealing the one semiconductor stock that stands to gain the most in a new FREE report. It's yours at no cost and with no obligation.
>>Yes, I Want to Help Protect My Portfolio During the Recession
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
AMETEK, Inc. (AME) : Free Stock Analysis Report
Semtech Corporation (SMTC) : Free Stock Analysis Report
DigitalOcean Holdings, Inc. (DOCN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Notably, Sustainable Hrvest Sdn Bhd has deployed LoRa sensors and LoRaWAN gateways across its Durian fruit farms in Malaysia. The LoRa chipsets connect sensors to the cloud and enable real-time communication of data and analytics, helping to enhance the efficiency and productivity of sustainable IoT use cases. The Zacks Consensus Estimate for AME’s second-quarter earnings is pegged at $1.50 per share, suggesting an increase of 8.7% from the prior-year quarter’s reported figure.
|
The Zacks Consensus Estimate for DOCN’s second-quarter earnings is pegged at 38 cents per share, suggesting a jump from 20 cents per share reported in the prior-year quarter. The Zacks Consensus Estimate for AME’s second-quarter earnings is pegged at $1.50 per share, suggesting an increase of 8.7% from the prior-year quarter’s reported figure. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report AMETEK, Inc. (AME) : Free Stock Analysis Report Semtech Corporation (SMTC) : Free Stock Analysis Report DigitalOcean Holdings, Inc. (DOCN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Semtech Corporation Price and Consensus Semtech Corporation price-consensus-chart | Semtech Corporation Quote Growth Prospects The company’s current move positions it well to capitalize on the growth prospects present in the global agriculture market. Investors interested in the broader Zacks Computer & Technology sector can consider some better-ranked stocks like Agilent Technologies A, DigitalOcean DOCN and AMETEK AME. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report AMETEK, Inc. (AME) : Free Stock Analysis Report Semtech Corporation (SMTC) : Free Stock Analysis Report DigitalOcean Holdings, Inc. (DOCN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The LoRa chipsets connect sensors to the cloud and enable real-time communication of data and analytics, helping to enhance the efficiency and productivity of sustainable IoT use cases. A report from Research and Markets states that the global agriculture market is expected to grow to $18,814.21 billion at a CAGR of 10.7% between 2022 and 2026. We note that expanding portfolio strength is expected to aid the company’s performance across the various end markets.
|
4ee126a1-f1a2-45ac-a963-db833993c55f
|
142.0
|
2023-05-12 00:00:00 UTC
|
With Top-Line Expansion Improve Keysight's (KEYS) Q2 Earnings?
|
A
|
https://www.nasdaq.com/articles/with-top-line-expansion-improve-keysights-keys-q2-earnings
|
nan
|
nan
|
Keysight Technologies, Inc. KEYS is scheduled to report second-quarter fiscal 2023 results on May 16 after market close. In the last reported quarter, the company delivered an earnings surprise of 9.19%. It pulled off a trailing four-quarter earnings surprise of 9.65%, on average.
The global leader in electronic design and test solutions is likely to report higher revenues year over year. The focus on technological innovation, collaboration with various industry partners and research institutes to drive technological advancement combined with a comprehensive product portfolio catering to various industry needs are expected to have boosted the top line.
Factors at Play
During the second quarter, Keysight partnered with Synopsys, an electronic products and software application developer, and Ansys, a simulation software provider, to augment the performance of Autonomous systems with 79Ghz millimeter wave (mmWave) radio frequency design flow. The collaboration leveraged RF design expertise from Keysight combined with Synopsys analog and mixed-signal design to support TSMC's (Taiwan Semiconductor Manufacturing Company) 16nm FinFET Compact Technology (16FFC).
Keysight also collaborated with the National Physical Laboratory (NPL) and the University of Surrey to demonstrate first 6G connection at a frequency of 300GHZ registering a speed of more than 100 Gbps. Keysight provides the necessary infrastructure for researchers to introduce groundbreaking technology platforms utilizing 5G advanced and 6G technologies. Such initiatives are likely to have boosted the top line during the quarter.
In the fiscal second quarter, Keysight introduced Novus Mini, a compact, cost-efficient network test solution that combined traffic generation and protocol testing in a single platform. It efficiently supports network engineers and enables them to perform compliance testing for automotive and loT applications. The company also announced that it has expanded its e-mobility charging test portfolio to accelerate the development of electric charging infrastructure and improve interoperability among e-mobility products. In addition to complementing its existing electric vehicle (EV) and electric vehicle supply equipment (EVSE) charging products, the portfolio expansion is likely to strengthen its leading position in the market.
During the quarter, Keysight validated the performance of Astella’s 5G Open RAN mmWave small cell base station. Astella Technologies, a Hong Kong-based O-RAN solution provider, opted to utilize Keysight Open RAN Architect (KORA) solutions to ensure that its product adheres to industry requirements to expedite commercial use. These developments are likely to have contributed to top-line growth in the quarter.
Keysight launched the Digital Learning Suite to support educators with a comprehensive platform that will allow them to deliver cutting-edge industry-ready training. The solution is dedicated toward developing the best-in-class tools to streamline digital learning and support students across all backgrounds. Keysight’s platform provides educators and students with one-stop access to lab resources and reduces the complexity of lab management. This time-efficient solution increases the real-time interaction between teachers and students and enhances overall productivity through test instrument control and data analysis tools.
In the quarter under review, Keysight collaborated with RISE Research Institutes of Sweden, KTH Royal Institute of Technology and Riga Technical University (RTU) to help innovate and develop the next-generation datacom optical interface. The partnership demonstrated greater Gbaud rates that will significantly improve information transmission capabilities. The new 75 GHz Keysight M8199B 256 GSa/s Arbitrary Waveform Generator combined with 110 GHz Keysight UXR1104A Infinium UXR-Series Oscilloscope was used during the demonstration.
Keysight partnered with NTT DOCOMO, Inc. and NTT to develop key technologies for 6G capabilities. The collaboration will likely promulgate affordable solutions to drive 6G wireless innovation to help bring this future communications technology to market. Such collaborations are likely to get reflected in the upcoming results.
For the April quarter, the Zacks Consensus Estimate for total revenues is pegged at $1,379 million, which indicates growth from $1,351 million reported in prior year quarter. The consensus estimate for adjusted earnings per share stands at $1.94, suggesting an increase from the prior-year quarter’s figure of $1.83.
Earnings Whispers
Our proven model does predict an earnings beat for Keysight in the second quarter. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is perfectly the case here.
Earnings ESP: Earnings ESP, which represents the difference between the Most Accurate Estimate and the Zacks Consensus Estimate, is +0.09%, with the former pegged at $1.95 and the latter at $1.94. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Keysight Technologies Inc. Price and EPS Surprise
Keysight Technologies Inc. price-eps-surprise | Keysight Technologies Inc. Quote
Zacks Rank: Keysight has a Zacks Rank #3 (Hold).
Other Stocks to Consider
Here are other companies you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season:
Agilent Technologies, Inc. A is set to release quarterly numbers on May 23. It has an Earnings ESP of +0.40% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Earnings ESP for Jabil, Inc. JBL is +3.38% and it carries a Zacks Rank of 3. The company is scheduled to report quarterly numbers on Jun 15.
The Earnings ESP for Splunk Inc. SPLK is +12.16% and it carries a Zacks Rank of 3. The company is scheduled to report quarterly numbers on May 24.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Jabil, Inc. (JBL) : Free Stock Analysis Report
Splunk Inc. (SPLK) : Free Stock Analysis Report
Keysight Technologies Inc. (KEYS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Keysight also collaborated with the National Physical Laboratory (NPL) and the University of Surrey to demonstrate first 6G connection at a frequency of 300GHZ registering a speed of more than 100 Gbps. Keysight launched the Digital Learning Suite to support educators with a comprehensive platform that will allow them to deliver cutting-edge industry-ready training. This time-efficient solution increases the real-time interaction between teachers and students and enhances overall productivity through test instrument control and data analysis tools.
|
The focus on technological innovation, collaboration with various industry partners and research institutes to drive technological advancement combined with a comprehensive product portfolio catering to various industry needs are expected to have boosted the top line. Keysight Technologies Inc. Price and EPS Surprise Keysight Technologies Inc. price-eps-surprise | Keysight Technologies Inc. Quote Zacks Rank: Keysight has a Zacks Rank #3 (Hold). Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Jabil, Inc. (JBL) : Free Stock Analysis Report Splunk Inc. (SPLK) : Free Stock Analysis Report Keysight Technologies Inc. (KEYS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. Keysight Technologies Inc. Price and EPS Surprise Keysight Technologies Inc. price-eps-surprise | Keysight Technologies Inc. Quote Zacks Rank: Keysight has a Zacks Rank #3 (Hold). Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Jabil, Inc. (JBL) : Free Stock Analysis Report Splunk Inc. (SPLK) : Free Stock Analysis Report Keysight Technologies Inc. (KEYS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In the last reported quarter, the company delivered an earnings surprise of 9.19%. The focus on technological innovation, collaboration with various industry partners and research institutes to drive technological advancement combined with a comprehensive product portfolio catering to various industry needs are expected to have boosted the top line. In the fiscal second quarter, Keysight introduced Novus Mini, a compact, cost-efficient network test solution that combined traffic generation and protocol testing in a single platform.
|
7de2f148-d8fc-42e1-9cdb-cccd645ee1bb
|
157.0
|
2023-05-08 00:00:00 UTC
|
Australia to deliver first budget surplus in 15 years
|
A
|
https://www.nasdaq.com/articles/australia-to-deliver-first-budget-surplus-in-15-years
|
nan
|
nan
|
SYDNEY, May 8 (Reuters) - Australia is set to deliver its first budget surplus in 15 years on Tuesday, as its coffers bulge with tax windfalls from higher commodities prices and wages, a political win for the centre-left Labor government since coming to power last May.
The budget will forecast a small surplus of around A$4 billion ($2.71 billion) for the fiscal year ending June, a huge turnaround from a projected deficit of A$36.9 billion in October, according to excerpts seen by Reuters.
Deficit estimates for the subsequent years have also been revised lower.
The government is returning 82% of revenue upgrades to the budget bottom-line while making $17.8 billion in savings and reprioritisations, based on the excerpts.
That brings the total savings found across the two budgets delivered so far by the Labor government to A$40 billion.
"Our responsible economic management is all about spending restraint, substantial savings redirected to other priorities, and modest but meaningful tax changes," said Treasurer Jim Chalmers.
"We are putting the Budget on a much more sustainable footing at the same time as we provide cost of living relief and invest in the future."
The government will also set aside a A$11.3 billion for wage rises for aged care workers and extend financial support for single parents.
($1 = 1.4758 Australian dollars)
(Reporting by Stella Qiu; Editing by Sam Holmes)
((yifan.qiu@thomsonreuters.com))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
SYDNEY, May 8 (Reuters) - Australia is set to deliver its first budget surplus in 15 years on Tuesday, as its coffers bulge with tax windfalls from higher commodities prices and wages, a political win for the centre-left Labor government since coming to power last May. "Our responsible economic management is all about spending restraint, substantial savings redirected to other priorities, and modest but meaningful tax changes," said Treasurer Jim Chalmers. The government will also set aside a A$11.3 billion for wage rises for aged care workers and extend financial support for single parents.
|
SYDNEY, May 8 (Reuters) - Australia is set to deliver its first budget surplus in 15 years on Tuesday, as its coffers bulge with tax windfalls from higher commodities prices and wages, a political win for the centre-left Labor government since coming to power last May. The budget will forecast a small surplus of around A$4 billion ($2.71 billion) for the fiscal year ending June, a huge turnaround from a projected deficit of A$36.9 billion in October, according to excerpts seen by Reuters. That brings the total savings found across the two budgets delivered so far by the Labor government to A$40 billion.
|
SYDNEY, May 8 (Reuters) - Australia is set to deliver its first budget surplus in 15 years on Tuesday, as its coffers bulge with tax windfalls from higher commodities prices and wages, a political win for the centre-left Labor government since coming to power last May. The budget will forecast a small surplus of around A$4 billion ($2.71 billion) for the fiscal year ending June, a huge turnaround from a projected deficit of A$36.9 billion in October, according to excerpts seen by Reuters. The government is returning 82% of revenue upgrades to the budget bottom-line while making $17.8 billion in savings and reprioritisations, based on the excerpts.
|
The budget will forecast a small surplus of around A$4 billion ($2.71 billion) for the fiscal year ending June, a huge turnaround from a projected deficit of A$36.9 billion in October, according to excerpts seen by Reuters. The government is returning 82% of revenue upgrades to the budget bottom-line while making $17.8 billion in savings and reprioritisations, based on the excerpts. That brings the total savings found across the two budgets delivered so far by the Labor government to A$40 billion.
|
b11e5c07-df7c-4db9-a9cf-3698defb2af7
|
168.0
|
2023-05-04 00:00:00 UTC
|
Advanced Energy (AEIS) Q1 Earnings Beat, Revenues Rise Y/Y
|
A
|
https://www.nasdaq.com/articles/advanced-energy-aeis-q1-earnings-beat-revenues-rise-y-y-0
|
nan
|
nan
|
Advanced Energy Industries, Inc. AEIS reported first-quarter 2023 non-GAAP earnings of $1.24 per share, beating the Zacks Consensus Estimate by 10.7%. The bottom line remained flat on a year-over-year basis.
Revenues of $425.04 million surpassed the Zacks Consensus Estimate of $411.13 million. The top line improved 7% year over year.
Strong momentum across the Industrial and Medical and Telecom and Networking end markets drove top-line growth in the reported quarter.
However, softness across Semiconductor Equipment and Data Center Computing markets was a concern.
Advanced Energy Industries, Inc. Price, Consensus and EPS Surprise
Advanced Energy Industries, Inc. price-consensus-eps-surprise-chart | Advanced Energy Industries, Inc. Quote
End Market in Detail
Semiconductor Equipment: Revenues generated from the market fell 4% year over year to $194.21 million (45.7% of the total revenues).
Nevertheless, solid demand for high voltage and growing design wins in etch and deposition were positives.
Industrial & Medical: Revenues from the market grew 48% year over year to $123.02 million (29% of the total revenues) in the reported quarter. Top-line growth in the market was driven by growing design wins in industrial and medical applications. Also, strong demand for thin film was a tailwind.
Data Center Computing: Revenues from the market were $59.7 million (14% of the total revenues), down 22% from the year-ago quarter’s level. Component shortage and weakening momentum among hyper-scale customers were concerns.
Telecom & Networking: Revenues generated from the market were $48.15 million (11.3% of the total revenues), up 36% from the prior-year quarter’s level.
Operating Results
In the first quarter, GAAP gross margin was 36.5%, which expanded 20 basis points (bps) year over year. The non-GAAP gross margin was 36.8%, expanding 20 bps from the year-ago quarter’s level.
Non-GAAP operating expenses were $99.7 million, up 13.8% year over year. As a percentage of revenues, the figure expanded 147 bps year over year to 23.5% in the reported quarter.
The non-GAAP operating margin was 13.4%, contracting 110 bps from the prior-year quarter’s level.
Balance Sheet & Cash Flow
As of Mar 31, 2023, cash and cash equivalents were $461.7 million compared with $458.82 million as of Dec 31, 2022.
Total debt was $368.4 million at the first-quarter end, down from $373.3 million at the fourth-quarter end.
For the first quarter, cash flow from operations was $31.9 million, which dropped from $70.7 million in the fourth quarter.
Advanced Energy made dividend payments of $3.8 million in the reported quarter.
Guidance
For second-quarter 2023, Advanced Energy expects non-GAAP earnings of $1.00 per share (+/- 25 cents). The Zacks Consensus Estimate is pegged at $1.13 per share.
Advanced Energy anticipates revenues of $410 million (+/- $20 million). The Zacks Consensus Estimate for the same is pegged at $417.39 million.
Zacks Rank & Stocks to Consider
Currently, Advanced Energy has a Zacks Rank #3 (Hold).
Investors interested in the broader technology sector can consider some better-ranked stocks like Agilent Technologies A, DigitalOcean DOCN and Paycor HCM PYCR, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Agilent Technologies is set to report second-quarter fiscal 2023 results on May 23. The Zacks Consensus Estimate for A’s earnings is pegged at $1.27 per share, implying growth of 12.4% from the year-ago quarter’s reported figure. A has lost 11.6% in the year-to-date period.
DigitalOcean is scheduled to release first-quarter 2023 results on May 9. The Zacks Consensus Estimate for DOCN’s earnings is pegged at 29 cents per share, suggesting a jump from 7 cents per share reported in the prior-year quarter. DOCN has gained 25.5% in the year-to-date period.
Paycor HCM is scheduled to report third-quarter fiscal 2023 results on May 10. The Zacks Consensus Estimate for PYCR’s earnings is pegged at 15 cents per share, suggesting an increase of 36.4% from the prior-year quarter’s reported figure. PYCR has gained 26% in the year-to-date period.
Top 5 ChatGPT Stocks Revealed
Zacks Senior Stock Strategist, Kevin Cook names 5 hand-picked stocks with sky-high growth potential in a brilliant sector of Artificial Intelligence. By 2030, the AI industry is predicted to have an internet and iPhone-scale economic impact of $15.7 Trillion.
Today you can invest in the wave of the future, an automation that answers follow-up questions … admits mistakes … challenges incorrect premises … rejects inappropriate requests. As one of the selected companies puts it, “Automation frees people from the mundane so they can accomplish the miraculous.”
Download Free ChatGPT Stock Report Right Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Advanced Energy Industries, Inc. (AEIS) : Free Stock Analysis Report
DigitalOcean Holdings, Inc. (DOCN) : Free Stock Analysis Report
Paycor HCM, Inc. (PYCR) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Advanced Energy Industries, Inc. AEIS reported first-quarter 2023 non-GAAP earnings of $1.24 per share, beating the Zacks Consensus Estimate by 10.7%. The Zacks Consensus Estimate for PYCR’s earnings is pegged at 15 cents per share, suggesting an increase of 36.4% from the prior-year quarter’s reported figure. Today you can invest in the wave of the future, an automation that answers follow-up questions … admits mistakes … challenges incorrect premises … rejects inappropriate requests.
|
Advanced Energy Industries, Inc. AEIS reported first-quarter 2023 non-GAAP earnings of $1.24 per share, beating the Zacks Consensus Estimate by 10.7%. Advanced Energy Industries, Inc. Price, Consensus and EPS Surprise Advanced Energy Industries, Inc. price-consensus-eps-surprise-chart | Advanced Energy Industries, Inc. Quote End Market in Detail Semiconductor Equipment: Revenues generated from the market fell 4% year over year to $194.21 million (45.7% of the total revenues). Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Advanced Energy Industries, Inc. (AEIS) : Free Stock Analysis Report DigitalOcean Holdings, Inc. (DOCN) : Free Stock Analysis Report Paycor HCM, Inc. (PYCR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Advanced Energy Industries, Inc. Price, Consensus and EPS Surprise Advanced Energy Industries, Inc. price-consensus-eps-surprise-chart | Advanced Energy Industries, Inc. Quote End Market in Detail Semiconductor Equipment: Revenues generated from the market fell 4% year over year to $194.21 million (45.7% of the total revenues). Industrial & Medical: Revenues from the market grew 48% year over year to $123.02 million (29% of the total revenues) in the reported quarter. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Advanced Energy Industries, Inc. (AEIS) : Free Stock Analysis Report DigitalOcean Holdings, Inc. (DOCN) : Free Stock Analysis Report Paycor HCM, Inc. (PYCR) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Advanced Energy Industries, Inc. AEIS reported first-quarter 2023 non-GAAP earnings of $1.24 per share, beating the Zacks Consensus Estimate by 10.7%. Revenues of $425.04 million surpassed the Zacks Consensus Estimate of $411.13 million. Advanced Energy Industries, Inc. Price, Consensus and EPS Surprise Advanced Energy Industries, Inc. price-consensus-eps-surprise-chart | Advanced Energy Industries, Inc. Quote End Market in Detail Semiconductor Equipment: Revenues generated from the market fell 4% year over year to $194.21 million (45.7% of the total revenues).
|
bed9d45f-c4bf-4100-8993-b140a9956ebd
|
185.0
|
2023-03-31 00:00:00 UTC
|
Bullish Two Hundred Day Moving Average Cross - A
|
A
|
https://www.nasdaq.com/articles/bullish-two-hundred-day-moving-average-cross-a
|
nan
|
nan
|
In trading on Friday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $137.71, changing hands as high as $138.73 per share. Agilent Technologies, Inc. shares are currently trading up about 2.9% on the day. The chart below shows the one year performance of A shares, versus its 200 day moving average:
Looking at the chart above, A's low point in its 52 week range is $112.52 per share, with $160.265 as the 52 week high point — that compares with a last trade of $137.98. The A DMA information above was sourced from TechnicalAnalysisChannel.com
Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average »
Also see:
SLGN Dividend Growth Rate
Institutional Holders of Adobe
Funds Holding AHP
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $137.71, changing hands as high as $138.73 per share. The chart below shows the one year performance of A shares, versus its 200 day moving average: Looking at the chart above, A's low point in its 52 week range is $112.52 per share, with $160.265 as the 52 week high point — that compares with a last trade of $137.98. The A DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average » Also see: SLGN Dividend Growth Rate Institutional Holders of Adobe Funds Holding AHP The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $137.71, changing hands as high as $138.73 per share. The chart below shows the one year performance of A shares, versus its 200 day moving average: Looking at the chart above, A's low point in its 52 week range is $112.52 per share, with $160.265 as the 52 week high point — that compares with a last trade of $137.98. The A DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average » Also see: SLGN Dividend Growth Rate Institutional Holders of Adobe Funds Holding AHP The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $137.71, changing hands as high as $138.73 per share. The chart below shows the one year performance of A shares, versus its 200 day moving average: Looking at the chart above, A's low point in its 52 week range is $112.52 per share, with $160.265 as the 52 week high point — that compares with a last trade of $137.98. The A DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average » Also see: SLGN Dividend Growth Rate Institutional Holders of Adobe Funds Holding AHP The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Friday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $137.71, changing hands as high as $138.73 per share. Agilent Technologies, Inc. shares are currently trading up about 2.9% on the day. The chart below shows the one year performance of A shares, versus its 200 day moving average: Looking at the chart above, A's low point in its 52 week range is $112.52 per share, with $160.265 as the 52 week high point — that compares with a last trade of $137.98.
|
bed82d2a-6566-4b80-99d4-46340aa086be
|
188.0
|
2023-03-30 00:00:00 UTC
|
Ex-Dividend Reminder: Agilent Technologies, Bank of Nova Scotia and Brixmor Property Group
|
A
|
https://www.nasdaq.com/articles/ex-dividend-reminder%3A-agilent-technologies-bank-of-nova-scotia-and-brixmor-property-group
|
nan
|
nan
|
Looking at the universe of stocks we cover at Dividend Channel, on 4/3/23, Agilent Technologies, Inc. (Symbol: A), Bank of Nova Scotia Halifax (Symbol: BNS), and Brixmor Property Group Inc (Symbol: BRX) will all trade ex-dividend for their respective upcoming dividends. Agilent Technologies, Inc. will pay its quarterly dividend of $0.225 on 4/26/23, Bank of Nova Scotia Halifax will pay its quarterly dividend of $1.03 on 4/26/23, and Brixmor Property Group Inc will pay its quarterly dividend of $0.26 on 4/17/23. As a percentage of A's recent stock price of $134.97, this dividend works out to approximately 0.17%, so look for shares of Agilent Technologies, Inc. to trade 0.17% lower — all else being equal — when A shares open for trading on 4/3/23. Similarly, investors should look for BNS to open 2.04% lower in price and for BRX to open 1.24% lower, all else being equal.
Below are dividend history charts for A, BNS, and BRX, showing historical dividends prior to the most recent ones declared.
Agilent Technologies, Inc. (Symbol: A):
Bank of Nova Scotia Halifax (Symbol: BNS):
Brixmor Property Group Inc (Symbol: BRX):
In general, dividends are not always predictable, following the ups and downs of company profits over time. Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. This can help in judging whether the most recent dividends from these companies are likely to continue. If they do continue, the current estimated yields on annualized basis would be 0.67% for Agilent Technologies, Inc., 8.16% for Bank of Nova Scotia Halifax, and 4.96% for Brixmor Property Group Inc.
In Thursday trading, Agilent Technologies, Inc. shares are currently up about 0.8%, Bank of Nova Scotia Halifax shares are up about 0.9%, and Brixmor Property Group Inc shares are up about 1.2% on the day.
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »
Also see:
Air Services Other Dividend Stocks
Top Ten Hedge Funds Holding USI
ADX Dividend History
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. If they do continue, the current estimated yields on annualized basis would be 0.67% for Agilent Technologies, Inc., 8.16% for Bank of Nova Scotia Halifax, and 4.96% for Brixmor Property Group Inc. dividend stocks should be on your radar screen » Also see: Air Services Other Dividend Stocks Top Ten Hedge Funds Holding USI ADX Dividend History The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Looking at the universe of stocks we cover at Dividend Channel, on 4/3/23, Agilent Technologies, Inc. (Symbol: A), Bank of Nova Scotia Halifax (Symbol: BNS), and Brixmor Property Group Inc (Symbol: BRX) will all trade ex-dividend for their respective upcoming dividends. Agilent Technologies, Inc. will pay its quarterly dividend of $0.225 on 4/26/23, Bank of Nova Scotia Halifax will pay its quarterly dividend of $1.03 on 4/26/23, and Brixmor Property Group Inc will pay its quarterly dividend of $0.26 on 4/17/23. Agilent Technologies, Inc. (Symbol: A): Bank of Nova Scotia Halifax (Symbol: BNS): Brixmor Property Group Inc (Symbol: BRX): In general, dividends are not always predictable, following the ups and downs of company profits over time.
|
Looking at the universe of stocks we cover at Dividend Channel, on 4/3/23, Agilent Technologies, Inc. (Symbol: A), Bank of Nova Scotia Halifax (Symbol: BNS), and Brixmor Property Group Inc (Symbol: BRX) will all trade ex-dividend for their respective upcoming dividends. Agilent Technologies, Inc. will pay its quarterly dividend of $0.225 on 4/26/23, Bank of Nova Scotia Halifax will pay its quarterly dividend of $1.03 on 4/26/23, and Brixmor Property Group Inc will pay its quarterly dividend of $0.26 on 4/17/23. Agilent Technologies, Inc. (Symbol: A): Bank of Nova Scotia Halifax (Symbol: BNS): Brixmor Property Group Inc (Symbol: BRX): In general, dividends are not always predictable, following the ups and downs of company profits over time.
|
As a percentage of A's recent stock price of $134.97, this dividend works out to approximately 0.17%, so look for shares of Agilent Technologies, Inc. to trade 0.17% lower — all else being equal — when A shares open for trading on 4/3/23. This can help in judging whether the most recent dividends from these companies are likely to continue. If they do continue, the current estimated yields on annualized basis would be 0.67% for Agilent Technologies, Inc., 8.16% for Bank of Nova Scotia Halifax, and 4.96% for Brixmor Property Group Inc.
|
7c24f0bc-d80e-4212-9afe-3bb1ff7fe10f
|
192.0
|
2023-03-21 00:00:00 UTC
|
US calls Tsai transit 'nothing new', urges China to not react aggressively
|
A
|
https://www.nasdaq.com/articles/us-calls-tsai-transit-nothing-new-urges-china-to-not-react-aggressively
|
nan
|
nan
|
By Michael Martina and Steve Holland
WASHINGTON, March 21 (Reuters) - Expected U.S. stopovers in coming weeks by Taiwan President Tsai Ing-wen are standard practice and China should not use them as a pretext for aggressive action toward the democratically governed island, a senior U.S. administration official said.
Tsai plans to transit through New York and Los Angeles as part of a trip to Central America, and sources have told Reuters that U.S. House Speaker Kevin McCarthy intends to meet her during the California leg of her visit.
China, which claims Taiwan as its territory, has said it is "seriously concerned" about Tsai's travel plans.
But the senior U.S. official told reporters on a call on Monday night that every president of Taiwan had transited through the U.S., and that Tsai has done so herself six times since taking office 2016, most recently in 2019.
She had met members of Congress during all of those visits, the official added, noting that the COVID-19 pandemic had limited her travel in more recent years.
"We see no reason for Beijing to turn this transit, again, which is consistent with long-standing U.S. policy, into anything but what it is. It should not be used as a pretext to step up any aggressive activity around the Taiwan Strait," the official said.
The official said Washington had communicated to Beijing that Tsai's stopovers are in keeping with past precedent.
"There is nothing new from our point of view," the official said.
Noting that President Joe Biden hoped to speak to Chinese leader Xi Jinping soon and that Secretary of State Antony Blinken would like to reschedule a postponed trip to Beijing, the official said: "We urge the PRC (People's Republic of China) to keep these channels of communication open."
"In terms of contact with McCarthy's office, we offer briefings to members before engagements. We tend to do that before travel, before meetings. We've had some regular contact there," the official added.
Tsai's anticipated U.S. meeting with McCarthy is seen as a potential alternative to a sensitive visit by the Republican Speaker to Taiwan, a trip he has said he hopes to make.
China staged military exercises around Taiwan in August following a visit to Taipei by then-U.S. House Speaker Nancy Pelosi.
Taiwan is China's most sensitive territorial issue and a major bone of contention with Washington, which maintains only unofficial ties with Taipei, but is required by U.S. law to provide the island with the means to defend itself.
China believes the United States is colluding with Taiwan to challenge Beijing and giving support to those who want the island to declare formal independence.
Taiwan's government says the People's Republic of China has never ruled the island and so has no right to claim it, and that only its 23 million people can decide their future.
(Reporting by Michael Martina and Steve Holland; Editing by Stephen Coates)
((michael.martina@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Michael Martina and Steve Holland WASHINGTON, March 21 (Reuters) - Expected U.S. stopovers in coming weeks by Taiwan President Tsai Ing-wen are standard practice and China should not use them as a pretext for aggressive action toward the democratically governed island, a senior U.S. administration official said. Tsai plans to transit through New York and Los Angeles as part of a trip to Central America, and sources have told Reuters that U.S. House Speaker Kevin McCarthy intends to meet her during the California leg of her visit. Noting that President Joe Biden hoped to speak to Chinese leader Xi Jinping soon and that Secretary of State Antony Blinken would like to reschedule a postponed trip to Beijing, the official said: "We urge the PRC (People's Republic of China) to keep these channels of communication open."
|
By Michael Martina and Steve Holland WASHINGTON, March 21 (Reuters) - Expected U.S. stopovers in coming weeks by Taiwan President Tsai Ing-wen are standard practice and China should not use them as a pretext for aggressive action toward the democratically governed island, a senior U.S. administration official said. Tsai plans to transit through New York and Los Angeles as part of a trip to Central America, and sources have told Reuters that U.S. House Speaker Kevin McCarthy intends to meet her during the California leg of her visit. But the senior U.S. official told reporters on a call on Monday night that every president of Taiwan had transited through the U.S., and that Tsai has done so herself six times since taking office 2016, most recently in 2019.
|
By Michael Martina and Steve Holland WASHINGTON, March 21 (Reuters) - Expected U.S. stopovers in coming weeks by Taiwan President Tsai Ing-wen are standard practice and China should not use them as a pretext for aggressive action toward the democratically governed island, a senior U.S. administration official said. But the senior U.S. official told reporters on a call on Monday night that every president of Taiwan had transited through the U.S., and that Tsai has done so herself six times since taking office 2016, most recently in 2019. Noting that President Joe Biden hoped to speak to Chinese leader Xi Jinping soon and that Secretary of State Antony Blinken would like to reschedule a postponed trip to Beijing, the official said: "We urge the PRC (People's Republic of China) to keep these channels of communication open."
|
By Michael Martina and Steve Holland WASHINGTON, March 21 (Reuters) - Expected U.S. stopovers in coming weeks by Taiwan President Tsai Ing-wen are standard practice and China should not use them as a pretext for aggressive action toward the democratically governed island, a senior U.S. administration official said. Tsai plans to transit through New York and Los Angeles as part of a trip to Central America, and sources have told Reuters that U.S. House Speaker Kevin McCarthy intends to meet her during the California leg of her visit. China, which claims Taiwan as its territory, has said it is "seriously concerned" about Tsai's travel plans.
|
31291fcb-0fed-4607-92d8-338b7f53e940
|
200.0
|
2023-03-09 00:00:00 UTC
|
MACOM (MTSI) Acquires Linearizer, Expands Product Portfolio
|
A
|
https://www.nasdaq.com/articles/macom-mtsi-acquires-linearizer-expands-product-portfolio
|
nan
|
nan
|
MACOM Technology Solutions MTSI has acquired Linearizer Communications Group ("LCG") for $49 million.
LCG is well-known for correcting distortion in communications systems and linear optical links. Moreover, the company focuses on non-linear microwave predistortion and high-performance microwave photonic solutions.
We note that MACOM’s component and subsystem design capabilities are likely to get enhanced upon the completion of the underlined buyout.
This, in turn, is expected to expand its end-market exposure, especially in the industrial and defense markets. Moreover, with LCG’s robust solutions, MACOM remains well-poised to gain solid momentum across terrestrial, avionic and space-based applications.
MACOM Technology Solutions Holdings, Inc. Price and Consensus
MACOM Technology Solutions Holdings, Inc. price-consensus-chart | MACOM Technology Solutions Holdings, Inc. Quote
Growth Prospects
The LCG acquisition is expected to expand MACOM’s footprint in the booming photonic solutions market.
According to a report from Fortune Business Insights, the global photonics market is expected to reach $1.3 trillion by 2028, at a CAGR of 6.7% between 2021 and 2028.
Per a Mordor Intelligence report, the market is anticipated to hit $1.1 trillion by 2027 at a CAGR of 7.5% between 2022 and 2027.
Notably, MACOM’s strong prospects, in this promising market on the back of the underlined acquisition, will likely aid its financial performance in the near future. Also, the prospects are expected to aid MTSI in winning investors’ confidence.
Coming to the price performance, MACOM has gained 20.5% in the past year, outperforming the industry’s growth of 12.9%.
Portfolio Strength
The latest move bodes well for the company’s growing efforts toward expanding its product portfolio.
Apart from LCG, MACOM recently signed a definitive agreement to buy the assets and operations of OMMIC SAS. Notably, this acquisition is expected to drive MACOM’s momentum in microwave applications across the telecommunications, industrial, and aerospace and defense markets. Further, it will boost MACOM’s wafer production capability.
Moreover, MTSI’s footprint in the European markets is expected to get strengthened upon the completion of the buyout.
In addition to strategic acquisitions, MTSI recently unveiled a 226Gbps per lane technology product family that comprises transimpedance amplifiers, MATA-40734 and MATA-40736, externally modulated laser driver, MAOM-011112 and a photodiode, MARP-BP112. Notably, the new product family aids the development of 1.6TB optical modules.
In addition, MTSI keeps bringing reliable and efficient technologies to provide better solutions to customers.
We believe that MACOM’s portfolio strength will continue to help it sustain momentum among customers.
Zacks Rank & Stocks to Consider
Currently, MACOM carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader technology sector are Arista Networks ANET, Agilent Technologies A and AMETEK AME. While Arista Networks sports a Zacks Rank #1 (Strong Buy), Agilent and AMETEK carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Arista Networks shares have gained 22.7% in the past year. The long-term earnings growth rate for ANET is currently projected at 14.17%.
Agilent shares have gained 4.9% in the past year. A’s long-term earnings growth rate is currently projected at 12%.
AMETEK shares have gained 9.8% in the past year. The long-term earnings growth rate for AME is currently projected at 8.81%.
Just Released: Zacks Top 10 Stocks for 2023
In addition to the investment ideas discussed above, would you like to know about our 10 top picks for 2023?
From inception in 2012 through November, the Zacks Top 10 Stocks portfolio has tripled the market, gaining an impressive +884.5% versus the S&P 500’s +287.4%. Our Director of Research has now combed through 4,000 companies covered by the Zacks Rank and handpicked the best 10 tickers to buy and hold in 2023. Don’t miss your chance to still be among the first to get in on these just-released stocks.
See New Top 10 Stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
AMETEK, Inc. (AME) : Free Stock Analysis Report
MACOM Technology Solutions Holdings, Inc. (MTSI) : Free Stock Analysis Report
Arista Networks, Inc. (ANET) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Moreover, with LCG’s robust solutions, MACOM remains well-poised to gain solid momentum across terrestrial, avionic and space-based applications. Notably, this acquisition is expected to drive MACOM’s momentum in microwave applications across the telecommunications, industrial, and aerospace and defense markets. In addition to strategic acquisitions, MTSI recently unveiled a 226Gbps per lane technology product family that comprises transimpedance amplifiers, MATA-40734 and MATA-40736, externally modulated laser driver, MAOM-011112 and a photodiode, MARP-BP112.
|
MACOM Technology Solutions Holdings, Inc. Price and Consensus MACOM Technology Solutions Holdings, Inc. price-consensus-chart | MACOM Technology Solutions Holdings, Inc. Quote Growth Prospects The LCG acquisition is expected to expand MACOM’s footprint in the booming photonic solutions market. While Arista Networks sports a Zacks Rank #1 (Strong Buy), Agilent and AMETEK carry a Zacks Rank #2 (Buy) at present. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report AMETEK, Inc. (AME) : Free Stock Analysis Report MACOM Technology Solutions Holdings, Inc. (MTSI) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
MACOM Technology Solutions Holdings, Inc. Price and Consensus MACOM Technology Solutions Holdings, Inc. price-consensus-chart | MACOM Technology Solutions Holdings, Inc. Quote Growth Prospects The LCG acquisition is expected to expand MACOM’s footprint in the booming photonic solutions market. Zacks Rank & Stocks to Consider Currently, MACOM carries a Zacks Rank #3 (Hold). Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report AMETEK, Inc. (AME) : Free Stock Analysis Report MACOM Technology Solutions Holdings, Inc. (MTSI) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
MACOM Technology Solutions Holdings, Inc. Price and Consensus MACOM Technology Solutions Holdings, Inc. price-consensus-chart | MACOM Technology Solutions Holdings, Inc. Quote Growth Prospects The LCG acquisition is expected to expand MACOM’s footprint in the booming photonic solutions market. Some better-ranked stocks in the broader technology sector are Arista Networks ANET, Agilent Technologies A and AMETEK AME. See New Top 10 Stocks >> Want the latest recommendations from Zacks Investment Research?
|
771a02ef-d8a0-4c1c-aa30-ca42f29c963e
|
212.0
|
2023-02-28 00:00:00 UTC
|
Agilent Technologies Q1 Profit Increases, beats estimates
|
A
|
https://www.nasdaq.com/articles/agilent-technologies-q1-profit-increases-beats-estimates
|
nan
|
nan
|
(RTTNews) - Agilent Technologies (A) revealed earnings for its first quarter that increased from the same period last year and beat the Street estimates.
The company's earnings came in at $352 million, or $1.19 per share. This compares with $283 million, or $0.93 per share, in last year's first quarter.
Excluding items, Agilent Technologies reported adjusted earnings of $406 million or $1.37 per share for the period.
Analysts on average had expected the company to earn $1.30 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 5.4% to $1.76 billion from $1.67 billion last year.
Agilent Technologies earnings at a glance (GAAP) :
-Earnings (Q1): $352 Mln. vs. $283 Mln. last year. -EPS (Q1): $1.19 vs. $0.93 last year. -Analyst Estimate: $1.30 -Revenue (Q1): $1.76 Bln vs. $1.67 Bln last year.
-Guidance: Next quarter EPS guidance: $1.24 - $1.27 Next quarter revenue guidance: $1.655 - $1.680 Bln Full year EPS guidance: $5.65 - $5.70 Full year revenue guidance: $7.03 - $7.10 Bln
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies (A) revealed earnings for its first quarter that increased from the same period last year and beat the Street estimates. Excluding items, Agilent Technologies reported adjusted earnings of $406 million or $1.37 per share for the period. Analysts on average had expected the company to earn $1.30 per share, according to figures compiled by Thomson Reuters.
|
Excluding items, Agilent Technologies reported adjusted earnings of $406 million or $1.37 per share for the period. -Analyst Estimate: $1.30 -Revenue (Q1): $1.76 Bln vs. $1.67 Bln last year. -Guidance: Next quarter EPS guidance: $1.24 - $1.27 Next quarter revenue guidance: $1.655 - $1.680 Bln Full year EPS guidance: $5.65 - $5.70 Full year revenue guidance: $7.03 - $7.10 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies (A) revealed earnings for its first quarter that increased from the same period last year and beat the Street estimates. Excluding items, Agilent Technologies reported adjusted earnings of $406 million or $1.37 per share for the period. -Guidance: Next quarter EPS guidance: $1.24 - $1.27 Next quarter revenue guidance: $1.655 - $1.680 Bln Full year EPS guidance: $5.65 - $5.70 Full year revenue guidance: $7.03 - $7.10 Bln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Excluding items, Agilent Technologies reported adjusted earnings of $406 million or $1.37 per share for the period. Agilent Technologies earnings at a glance (GAAP) : -Earnings (Q1): $352 Mln. -Analyst Estimate: $1.30 -Revenue (Q1): $1.76 Bln vs. $1.67 Bln last year.
|
f18d317b-de50-417a-8caa-4cf6a6c106d8
|
213.0
|
2023-02-28 00:00:00 UTC
|
Agilent Technologies Q1 23 Earnings Conference Call At 4:30 PM ET
|
A
|
https://www.nasdaq.com/articles/agilent-technologies-q1-23-earnings-conference-call-at-4%3A30-pm-et
|
nan
|
nan
|
(RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on February 28, 2023, to discuss Q1 23 earnings results.
To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on February 28, 2023, to discuss Q1 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on February 28, 2023, to discuss Q1 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on February 28, 2023, to discuss Q1 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on February 28, 2023, to discuss Q1 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
b554e55d-a979-42b9-8e1e-cee869640abc
|
263.0
|
2023-01-26 00:00:00 UTC
|
Best Growth Stocks to Buy for January 26th
|
A
|
https://www.nasdaq.com/articles/best-growth-stocks-to-buy-for-january-26th-0
|
nan
|
nan
|
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 26th:
Agilent Technologies, Inc. A: This application-focused solutions provider to the life sciences, diagnostics, and applied chemical markets carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Agilent Technologies, Inc. Price and Consensus
Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote
Agilent has a PEG ratio of 2.76 compared with 5.26 for the industry. The company possesses a Growth Score of B.
Agilent Technologies, Inc. PEG Ratio (TTM)
Agilent Technologies, Inc. peg-ratio-ttm | Agilent Technologies, Inc. Quote
Wolters Kluwer N.V. WTKWY: This professional information, software solutions, and services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.
Wolters Kluwer NV Price and Consensus
Wolters Kluwer NV price-consensus-chart | Wolters Kluwer NV Quote
Wolters Kluwer has a PEG ratio of 2.01 compared with 2.42 for the industry. The company possesses a Growth Score of A.
Wolters Kluwer NV PEG Ratio (TTM)
Wolters Kluwer NV peg-ratio-ttm | Wolters Kluwer NV Quote
KnowBe4, Inc. KNBE: This company that engages in the development, marketing, and sale of its Software-as-a-Service-based security awareness platform carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days.
KnowBe4, Inc. Price and Consensus
KnowBe4, Inc. price-consensus-chart | KnowBe4, Inc. Quote
KnowBe4 has a PEG ratio of 1.61 compared with 2.31 for the industry. The company possesses a Growth Score of A.
KnowBe4, Inc. PEG Ratio (TTM)
KnowBe4, Inc. peg-ratio-ttm | KnowBe4, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Free Report: Must-See Energy Stocks for 2023
Record profits at oil companies can mean big gains for you. With soaring demand and elevated prices, oil stocks could be top performers by far in 2023. Zacks has released a special report revealing the 4 oil stocks experts believe will deliver the biggest gains. (You’ll never guess Stock #2!)
Download Oil Market on Fire today, absolutely free.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Wolters Kluwer NV (WTKWY) : Free Stock Analysis Report
KnowBe4, Inc. (KNBE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 26th: Agilent Technologies, Inc. A: This application-focused solutions provider to the life sciences, diagnostics, and applied chemical markets carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days. The company possesses a Growth Score of A. KnowBe4, Inc. PEG Ratio (TTM) KnowBe4, Inc. peg-ratio-ttm | KnowBe4, Inc. Quote See the full list of top ranked stocks here. Free Report: Must-See Energy Stocks for 2023 Record profits at oil companies can mean big gains for you.
|
The company possesses a Growth Score of B. Agilent Technologies, Inc. PEG Ratio (TTM) Agilent Technologies, Inc. peg-ratio-ttm | Agilent Technologies, Inc. Quote Wolters Kluwer N.V. WTKWY: This professional information, software solutions, and services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days. The company possesses a Growth Score of A. Wolters Kluwer NV PEG Ratio (TTM) Wolters Kluwer NV peg-ratio-ttm | Wolters Kluwer NV Quote KnowBe4, Inc. KNBE: This company that engages in the development, marketing, and sale of its Software-as-a-Service-based security awareness platform carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Wolters Kluwer NV (WTKWY) : Free Stock Analysis Report KnowBe4, Inc. (KNBE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The company possesses a Growth Score of B. Agilent Technologies, Inc. PEG Ratio (TTM) Agilent Technologies, Inc. peg-ratio-ttm | Agilent Technologies, Inc. Quote Wolters Kluwer N.V. WTKWY: This professional information, software solutions, and services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days. The company possesses a Growth Score of A. Wolters Kluwer NV PEG Ratio (TTM) Wolters Kluwer NV peg-ratio-ttm | Wolters Kluwer NV Quote KnowBe4, Inc. KNBE: This company that engages in the development, marketing, and sale of its Software-as-a-Service-based security awareness platform carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.7% over the last 60 days. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Wolters Kluwer NV (WTKWY) : Free Stock Analysis Report KnowBe4, Inc. (KNBE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The company possesses a Growth Score of B. Agilent Technologies, Inc. PEG Ratio (TTM) Agilent Technologies, Inc. peg-ratio-ttm | Agilent Technologies, Inc. Quote Wolters Kluwer N.V. WTKWY: This professional information, software solutions, and services company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days. The company possesses a Growth Score of A. KnowBe4, Inc. PEG Ratio (TTM) KnowBe4, Inc. peg-ratio-ttm | KnowBe4, Inc. Quote See the full list of top ranked stocks here. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Wolters Kluwer NV (WTKWY) : Free Stock Analysis Report KnowBe4, Inc. (KNBE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
73ad55ad-e159-4ed9-980c-31ef5e165c01
|
266.0
|
2023-01-23 00:00:00 UTC
|
Agilent Inks Deal With Quest Diagnostics To Offer CtDx FIRST Liquid Biopsy Test Across US
|
A
|
https://www.nasdaq.com/articles/agilent-inks-deal-with-quest-diagnostics-to-offer-ctdx-first-liquid-biopsy-test-across-us
|
nan
|
nan
|
(RTTNews) - Agilent Technologies, Inc. (A) announced Monday an agreement with Quest Diagnostics (DGX), a diagnostic information services company, to enable providers and patients throughout the U.S. to access the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test.
Healthcare providers can now order the test electronically through the Quest connectivity platform, which connects to hundreds of electronic medical records (EMRs). They may direct patients to provide specimens at one of Quest's 2,100 patient service centers across the U.S.
The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolution Bioscience CLIA laboratory in Kirkland, Washington.
ctDx FIRST is the first liquid biopsy test approved by the U.S. Food and Drug Administration (FDA) as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients who may benefit from treatment with KRAZATI. It is a minimally invasive liquid biopsy test option as a CDx for KRAZATI.
KRAZATI (adagrasib) received accelerated approval as a targeted treatment option for adult patients with KRASG12C-mutated locally advanced or metastatic NSCLC, as determined by an FDA-approved test, who have received at least one prior systemic therapy. As a professional service, the ctDx FIRST test report includes comprehensive genomic profiling on 109 genes across four types of alterations: single nucleotide variants, indels, copy number amplifications, and fusions.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolution Bioscience CLIA laboratory in Kirkland, Washington. ctDx FIRST is the first liquid biopsy test approved by the U.S. Food and Drug Administration (FDA) as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients who may benefit from treatment with KRAZATI. As a professional service, the ctDx FIRST test report includes comprehensive genomic profiling on 109 genes across four types of alterations: single nucleotide variants, indels, copy number amplifications, and fusions.
|
(RTTNews) - Agilent Technologies, Inc. (A) announced Monday an agreement with Quest Diagnostics (DGX), a diagnostic information services company, to enable providers and patients throughout the U.S. to access the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test. ctDx FIRST is the first liquid biopsy test approved by the U.S. Food and Drug Administration (FDA) as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients who may benefit from treatment with KRAZATI. It is a minimally invasive liquid biopsy test option as a CDx for KRAZATI.
|
(RTTNews) - Agilent Technologies, Inc. (A) announced Monday an agreement with Quest Diagnostics (DGX), a diagnostic information services company, to enable providers and patients throughout the U.S. to access the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test. ctDx FIRST is the first liquid biopsy test approved by the U.S. Food and Drug Administration (FDA) as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients who may benefit from treatment with KRAZATI. KRAZATI (adagrasib) received accelerated approval as a targeted treatment option for adult patients with KRASG12C-mutated locally advanced or metastatic NSCLC, as determined by an FDA-approved test, who have received at least one prior systemic therapy.
|
(RTTNews) - Agilent Technologies, Inc. (A) announced Monday an agreement with Quest Diagnostics (DGX), a diagnostic information services company, to enable providers and patients throughout the U.S. to access the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test. Healthcare providers can now order the test electronically through the Quest connectivity platform, which connects to hundreds of electronic medical records (EMRs). ctDx FIRST is the first liquid biopsy test approved by the U.S. Food and Drug Administration (FDA) as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients who may benefit from treatment with KRAZATI.
|
349a67bb-dc5b-496b-809e-fa0f7505771c
|
271.0
|
2023-01-19 00:00:00 UTC
|
Texas Instruments (TXN) Introduces Ultrasonic Lens Chipsets
|
A
|
https://www.nasdaq.com/articles/texas-instruments-txn-introduces-ultrasonic-lens-chipsets
|
nan
|
nan
|
Texas Instruments TXN launched ultrasonic lens cleaning semiconductors named the ULC1001 digital signal processor and companion DRV2901 piezo transducer driver.
Featuring a proprietary technology, the chipsets use microscopic vibrations to enable camera systems in quickly detecting and removing contaminants from camera lenses.
With the new ultrasonic lens cleaning chipsets, TXN focuses on improving system accuracy and thereby reducing maintenance requirements.
The semiconductors will cater to the growing need of simple and self-cleaning cameras and sensors in various automotive and industrial applications.
On the back of ultrasonic lens cleaning chipsets, Texas Instruments is expected to gain momentum among customers. This, in turn, will contribute well to the company’s top-line growth.
Consequently, this will help Texas Instruments win the confidence of the investors in the near and long terms.
Shares of TXN have been up 0.2% in the past year against the Zacks Computer and Technology sector’s decline of 24.8%.
Texas Instruments Incorporated Price and Consensus
Texas Instruments Incorporated price-consensus-chart | Texas Instruments Incorporated Quote
Expanding Portfolio Offerings
The recent introduction of chipsets bodes well with the company’s growing efforts toward expanding its portfolio of solutions.
Apart from the recent launch, the company unveiled the latest portfolio of isolated solid-state relays to help engineers reduce the cost and size of high-voltage power supplies while maintaining safe electric vehicles.
It introduced a radar sensor called AWR2944 to strengthen its presence in the booming ADAS market. AWR2944 is a 77 GHz sensor integrating a fourth transmitter to provide 33% higher resolution than the existing radar sensors.
It also introduced the 3D Hall-effect position sensor named TMAG5170. With the help of this sensor, engineers are able to get uncalibrated ultra-high precision at high speed for quick and accurate real-time control in factory automation and motor-drive applications.
Though Texas Instruments’ growing portfolio solutions remain a positive, the imposition of new export regulations and softness in the personal electronics end-market remains a headwind.
Zacks Rank & Stocks to Consider
Currently, Texas Instruments has a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader Zacks Computer & Technology sector are Arista Networks ANET, Agilent Technologies A and Asure Software ASUR, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Arista Networks has lost 5.7% in the past year. The long-term earnings growth rate for ANET is currently projected at 17.5%.
Agilent has gained 10.5% in the past year. A’s long-term earnings growth rate is currently projected at 10%.
Asure Software has gained 35.8% in the past year. The long-term earnings growth rate for ASUR is currently projected at 23%.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.8% per year. So be sure to give these hand-picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Texas Instruments Incorporated (TXN) : Free Stock Analysis Report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Asure Software Inc (ASUR) : Free Stock Analysis Report
Arista Networks, Inc. (ANET) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Texas Instruments TXN launched ultrasonic lens cleaning semiconductors named the ULC1001 digital signal processor and companion DRV2901 piezo transducer driver. Apart from the recent launch, the company unveiled the latest portfolio of isolated solid-state relays to help engineers reduce the cost and size of high-voltage power supplies while maintaining safe electric vehicles. With the help of this sensor, engineers are able to get uncalibrated ultra-high precision at high speed for quick and accurate real-time control in factory automation and motor-drive applications.
|
Texas Instruments TXN launched ultrasonic lens cleaning semiconductors named the ULC1001 digital signal processor and companion DRV2901 piezo transducer driver. Some better-ranked stocks in the broader Zacks Computer & Technology sector are Arista Networks ANET, Agilent Technologies A and Asure Software ASUR, each carrying a Zacks Rank #2 (Buy) at present. Click to get this free report Texas Instruments Incorporated (TXN) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Texas Instruments Incorporated Price and Consensus Texas Instruments Incorporated price-consensus-chart | Texas Instruments Incorporated Quote Expanding Portfolio Offerings The recent introduction of chipsets bodes well with the company’s growing efforts toward expanding its portfolio of solutions. Some better-ranked stocks in the broader Zacks Computer & Technology sector are Arista Networks ANET, Agilent Technologies A and Asure Software ASUR, each carrying a Zacks Rank #2 (Buy) at present. Click to get this free report Texas Instruments Incorporated (TXN) : Free Stock Analysis Report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Texas Instruments Incorporated Price and Consensus Texas Instruments Incorporated price-consensus-chart | Texas Instruments Incorporated Quote Expanding Portfolio Offerings The recent introduction of chipsets bodes well with the company’s growing efforts toward expanding its portfolio of solutions. Some better-ranked stocks in the broader Zacks Computer & Technology sector are Arista Networks ANET, Agilent Technologies A and Asure Software ASUR, each carrying a Zacks Rank #2 (Buy) at present. Asure Software has gained 35.8% in the past year.
|
a1171d0b-7749-428c-b276-10af9553c230
|
275.0
|
2023-01-18 00:00:00 UTC
|
Jack Henry (JKHY) Expands Credit Card Offerings With TIB
|
A
|
https://www.nasdaq.com/articles/jack-henry-jkhy-expands-credit-card-offerings-with-tib
|
nan
|
nan
|
Jack Henry & Associates JKHY expanded its credit card offering in partnership with TIB to strengthen its payment solutions portfolio.
Jack Henry is leveraging TIB’s Agent Credit Card program for this purpose.
With this program, Jack Henry will help various financial institutions to issue credit cards seamlessly.
Financial institutions will be able to purchase and transform their agent portfolios into in-house and self-managed ones on the back of the Agent Credit Card program.
The program’s robust relationship-based underwriting process will allow these institutions to leverage higher approval and card usage rates.
Given these benefits, we believe that Jack Henry will gain solid momentum among financial institutions, which, in turn, will strengthen its customer base.
Expanding Portfolio
The latest move bodes well for the company’s growing efforts toward expanding its solutions portfolio.
Recently, Jack Henry unveiled a policy management solution that streamlines policy creation, review, approvals, attestations, and exceptions with workflows, documentation and storage on a single platform.
Additionally, the company’s recent acquisition of Payrailz remains noteworthy. The buyout allows Jack Henry to aid financial institutions to cater to the needs of consumers and commercial accountholders seamlessly.
On the back of the buyout, JKHY rolled out its standalone person-to-person payment solutions.
Growing Customer Base
An expanding solutions portfolio continues to aid Jack Henry in gaining strong customer momentum.
Recently, the company’s Symitar platform was selected by L&N Federal Credit Union. The latter strives to build and offer solutions through fintech relationships, equip its members with advanced tools, streamline its operations, and boost efficiencies on the back of Symitar.
Further, JKHY got picked by TIB last month. TIB is leveraging the former’s technology platform to support near and long-term operations.
We believe that growing customer momentum will continue to aid the company in winning investor confidence in the near term.
Shares of Jack Henry have gained 10% in the past year against the industry’s decline of 1%.
However, the company is suffering from mounting expenditure. Rising headcounts and personnel costs are weighing on margin expansion. Also, increasing expenses related to the card processing platform are concerning.
Zacks Rank & Stocks to Consider
Currently, Jack Henry carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader Zacks Computer & Technology sector are Arista Networks ANET, Agilent technologies A and Asure Software ASUR. All companies carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Arista Networks has lost 8.5% in the past year. The long-term earnings growth rate for ANET is projected at 17.5%.
Agilent has gained 10.6% in the past year. A’s long-term earnings growth rate is projected at 10%.
Asure Software has gained 37.9% in the past year. The long-term earnings growth rate for ASUR is projected at 23%.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Jack Henry & Associates, Inc. (JKHY) : Free Stock Analysis Report
Asure Software Inc (ASUR) : Free Stock Analysis Report
Arista Networks, Inc. (ANET) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Jack Henry & Associates JKHY expanded its credit card offering in partnership with TIB to strengthen its payment solutions portfolio. Given these benefits, we believe that Jack Henry will gain solid momentum among financial institutions, which, in turn, will strengthen its customer base. The latter strives to build and offer solutions through fintech relationships, equip its members with advanced tools, streamline its operations, and boost efficiencies on the back of Symitar.
|
Jack Henry & Associates JKHY expanded its credit card offering in partnership with TIB to strengthen its payment solutions portfolio. Growing Customer Base An expanding solutions portfolio continues to aid Jack Henry in gaining strong customer momentum. Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Jack Henry & Associates, Inc. (JKHY) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Jack Henry & Associates JKHY expanded its credit card offering in partnership with TIB to strengthen its payment solutions portfolio. Zacks Rank & Stocks to Consider Currently, Jack Henry carries a Zacks Rank #4 (Sell). Click to get this free report Agilent Technologies, Inc. (A) : Free Stock Analysis Report Jack Henry & Associates, Inc. (JKHY) : Free Stock Analysis Report Asure Software Inc (ASUR) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Jack Henry & Associates JKHY expanded its credit card offering in partnership with TIB to strengthen its payment solutions portfolio. TIB is leveraging the former’s technology platform to support near and long-term operations. Today, See These 5 Potential Home Runs >> Want the latest recommendations from Zacks Investment Research?
|
0a345016-997b-42e2-937a-67d97ec88f2e
|
280.0
|
2023-01-16 00:00:00 UTC
|
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now
|
A
|
https://www.nasdaq.com/articles/if-you-invested-%241000-in-agilent-technologies-a-decade-ago-this-is-how-much-itd-be-worth
|
nan
|
nan
|
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and industries.
FOMO, or the fear of missing out, also plays a role in investing, particularly with tech giants and popular consumer-facing stocks.
What if you'd invested in Agilent Technologies (A) ten years ago? It may not have been easy to hold on to A for all that time, but if you did, how much would your investment be worth today?
Agilent Technologies' Business In-Depth
With that in mind, let's take a look at Agilent Technologies' main business drivers.
Palo Alto, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets.
On Nov 1, 2014, Agilent completed the spinoff of its electronic measurement segment into a new company named Keysight Technologies, making it an independent, publicly traded company.
Over the last three years, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).
The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce, as necessary.
Agilent reported revenues of $6.3 billion in fiscal 2021, up 18% from fiscal 2020. The company generated 62% of revenues from markets outside the United States. 35% were derived from Asia-Pacific region in the fiscal 2021.
LSAG accounted for 45% of fiscal 2021 revenues (up 18% from fiscal 2020), DGG contributed 20% (which increased 24% from fiscal 2020) and ACG represented the remaining 35% (improving 16% from fiscal 2020).
Most of the competition for these three segments comes from Bruker Corp., Danaher Corp, Affymetrix, GE Healthcare, Life Technologies Corp., Thermo Fisher Scientific, Waters Corp., Illumina, Inc., Life Technologies Corp., Abbott Laboratories, Sakura, Roche, Perkin Elmer Corp., Shimadzu Corp, Heidenhain Corp., Malvern Instruments, Seiko Instruments, Veeco Instruments and Zygo Corp.
Bottom Line
Anyone can invest, but building a successful investment portfolio takes a combination of a few things: research, patience, and a little bit of risk. So, if you had invested in Agilent Technologies a decade ago, you're probably feeling pretty good about your investment today.
According to our calculations, a $1000 investment made in January 2013 would be worth $3,613.17, or a gain of 261.32%, as of January 16, 2023, and this return excludes dividends but includes price increases.
In comparison, the S&P 500 gained 171.67% and the price of gold went up 9.90% over the same time frame.
Analysts are forecasting more upside for A too.
Agilent is benefiting from continued strong momentum in the pharma and applied markets. Additionally, strength in the Life Sciences & Applied Markets Group (LSAG) segment owing to growth in Liquid Chromatography and Mass Spectrometry instruments remains a major positive. Increase in service agreement attach rate is driving the Agilent Cross Lab Group (ACG) segment. Strength in NASD and Genomics portfolio is contributing well to the Diagnostics and Genomics Group (DGG) segment. We expect LSAG, ACG and DGG segments to grow 0.9%, 0.4% and 1.5% in fiscal 2023 from the year-ago reported figures. However, mounting expenses might hurt the company’s profitability. Our estimate suggests total costs and expenses to witness a year-over-year rise of 4.6% in fiscal 2023. The ongoing conflict in Ukraine remains an overhang as well.
The stock has jumped 5.10% over the past four weeks. Additionally, no earnings estimate has gone lower in the past two months, compared to 8 higher, for fiscal 2023; the consensus estimate has moved up as well.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce, as necessary. Additionally, strength in the Life Sciences & Applied Markets Group (LSAG) segment owing to growth in Liquid Chromatography and Mass Spectrometry instruments remains a major positive.
|
The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). LSAG accounted for 45% of fiscal 2021 revenues (up 18% from fiscal 2020), DGG contributed 20% (which increased 24% from fiscal 2020) and ACG represented the remaining 35% (improving 16% from fiscal 2020). Additionally, strength in the Life Sciences & Applied Markets Group (LSAG) segment owing to growth in Liquid Chromatography and Mass Spectrometry instruments remains a major positive.
|
The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). LSAG accounted for 45% of fiscal 2021 revenues (up 18% from fiscal 2020), DGG contributed 20% (which increased 24% from fiscal 2020) and ACG represented the remaining 35% (improving 16% from fiscal 2020). Most of the competition for these three segments comes from Bruker Corp., Danaher Corp, Affymetrix, GE Healthcare, Life Technologies Corp., Thermo Fisher Scientific, Waters Corp., Illumina, Inc., Life Technologies Corp., Abbott Laboratories, Sakura, Roche, Perkin Elmer Corp., Shimadzu Corp, Heidenhain Corp., Malvern Instruments, Seiko Instruments, Veeco Instruments and Zygo Corp. Bottom Line Anyone can invest, but building a successful investment portfolio takes a combination of a few things: research, patience, and a little bit of risk.
|
Over the last three years, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). Agilent reported revenues of $6.3 billion in fiscal 2021, up 18% from fiscal 2020.
|
d2d50ffc-9748-425b-83a2-310b5aca65fb
|
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 8